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Introduction
Introduction
A fistula is defined as an abnormal communication between two epithelium lined surfaces. 
Perianal fistulas are abnormal communications between the anal canal and the perianal skin. 
Perianal fistulas have been treated since ancient times. Probably the first to describe the 
diagnosis  and  treatment  of  anal  fistula  was  Sushruta  around  600  BC.  Around  430  BC, 
Hippocrates (460-370 BC) described perianal fistulas in more detail  1. It is remarkable that 
some of his guidelines carry worldwide popularity up to today. The estimated incidence of 
perianal  fistulas  varies  between  0.86  and  2.32  per  10,000/year  2,  3.  There  is  a  male 
predominance  with  a  reported  male-to-female-ratio  varying  from  2:1  to  5:1  2,  4-6.  The 
maximum incidence is between the third and fifth decades of life 2. Perianal fistulas account 
for a substantial discomfort and morbidity to the patient and although many fistulas are easily 
recognized and treated, others can be complex and difficult to treat. 
Aetiology and pathogenesis
The majority of perianal fistulas are of cryptoglandular origin. The cryptoglandular hypothesis 
states that perianal fistulas arise from anal canal glands, located at the level of the dentate 
line7. The ducts of these glands flow into the crypts of Morgagni and drain into the anal canal. 
If these glands become blocked, stasis occurs and infection develops. Because a substantial 
number of these glands branch out into the intersphincteric plane, the infection can pass the 
internal  anal sphincter  that serves as a barrier  against  bacterial  contamination.  From the 
intersphincteric  plane  the  infection  may  progress  and  extend  in  various  ways.  Patients 
usually  present  with  an  abscess.  In  about  half  of  these  patients  a  fistula  persists  after 
drainage of the abscess. Among more specific causes for perianal fistulas Crohn’s disease is 
a major one. Iatrogenic and obstetric trauma may also result in a perianal fistula. Perianal 
fistulas in specific  conditions,  such as tuberculosis,  HIV or malignant  diseases are rarely 
seen.
Anatomy
A thorough knowledge of the anatomy of the anal canal, rectum, anal sphincters and the 
pelvic floor is essential for a correct classification of perianal fistulas and their treatment. The 
anal canal extends from the rectal ampulla to the anal verge and is 2-5 centimeters in length. 
The upper part is lined with columnar epithelium. The dentate line is situated in the distal part 
of the anal canal and is defined by the columns of Morgagni (Figure 1.1). At this level the 
ducts of the anal glands flow into the anal crypts. At the dentate line the epithelium becomes 
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transitional and is referred to as the anal transition zone. Distal from this zone the anal canal 
is lined with stratified squamous epithelium. The anal canal is surrounded by the internal and 
external sphincter muscle. 
Although fecal continence depends on many factors, the function of the anal sphincters is 
considered the most important one.  The internal anal sphincter consists of smooth muscle 
and  is  innervated  by  the  autonomic  nervous  system  while  the  external  anal  sphincter 
consists of striated skeletal muscle and has somatic innervation. The external anal sphincter 
is unique compared to other striated muscles regarding its continuous tonic activity. At the 
upper  level  the external  anal  sphincter  becomes continuous with  the puborectal  muscle, 
which forms a sling behind the anal canal and is attached to the pubic bone. The puborectal 
muscle is part of the levator ani muscle, a broad thin muscle that forms the pelvic floor. Both 
the high-pressure zone in the anal canal and the angulation between the rectum and anal 
canal, which is a result of the tonic contraction of the puborectal muscle, contribute to fecal 
continence.  Both anal sphincters are responsible for the anal high-pressure zone at rest, 
however  the  internal  anal  sphincter  supplies  the  largest  contribution  to  this  anal  resting 
pressure. 
Figure 1.1 Anatomy of the anal canal
(reprinted with the permission from P.H. Gordon)
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Classification
In 1976 Parks combined anatomical features with the cryptoglandular hypothesis to develop 
a classification of perianal fistulas, which is now generally used 8.  Parks classified perianal 
fistulas by their location in relation to the anal sphincter muscles and defined four types of 
fistulas (Figure 1.2). 
1. Intersphincteric fistula. The fistulous tract traverses the internal sphincter and extends in 
the intersphincteric space to the perianal skin. 
2.  Transsphincteric fistula. The tract  traverses both the internal  and external  sphincter 
muscles. 
3. Suprasphincteric fistula. The tract passes the internal anal sphincter, turns upward in 
the intersphincteric space to a point above the puborectal muscle, crosses this muscle, then 
extends downward between the puborectal and levator ani muscle to the external opening. 
4. Extrasphincteric fistula. The tract begins at the rectum or sigmoid colon and extends 
downward and passes through the levator ani muscle to the external opening. 
Figure 1.2 Classification of perianal fistulas
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Transsphincteric fistulas are subdivided into high and low transsphincteric fistulas, based on 
the level at  which they traverse the external anal sphincter.  Fistulas passing through the 
distal  third  of  the  external  anal  sphincter are classified  as low,  whereas  fistulas passing 
through the middle or proximal third of the external anal sphincter are referred to as high. 
This distinction is important because of the surgical implications. Low transsphincteric fistulas 
can be treated with either fistulotomy (lay-open) or fistulectomy (excision).  This will result in 
division  of  only  a  small  portion  of  the  external  anal  sphincter  and  with  only  minimal 
continence disturbances as a result. However, in case of a high transsphincteric fistula the 
portion  of  the  external  sphincter  that  needs  to  be  divided  is  too  large  and  continence 
disturbances are inevitable.  This type of fistula requires a more vigilant  treatment option, 
such as the transanal advancement flap repair. 
Clinical manifestation
Signs and symptoms 
Perianal fistulas are associated with pain and discharge of purulent material or blood9. The 
history  of  patients  with  a  perianal  fistula  frequently  reveals  cyclic  periods  in  which  the 
external opening of the fistula temporarily closes. This may result in an increase of pain and 
swelling. 
Physical examination
Physical  examination  remains  the  mainstay  of  diagnosis.  One  should  inspect  the  entire 
perineum,  looking  for  external  openings.  Spontaneous  discharge  through  the  external 
opening or discharge expressible upon palpation or digital rectal examination may be noted. 
Sometimes an elevation of granulation tissue marks the external opening. The location of the 
external  opening provides information  about  the location of  the internal  opening and the 
course of the fistulous tract. The relation between the internal and external opening and the 
course of the fistulous tract was described in 1900 by Goodsall 10. His guidelines have been 
almost universally accepted and are commonly known as Goodsall’s rule. According to this 
rule, fistulas with an external opening posterior to a plane transverse through the centre of 
the anus are likely to have their internal opening posterior in the midline and extend in a 
curved  way  to  the  external  opening,  whereas  fistulas  with  their  external  opening  in  the 
anterior part of the anal canal are likely to originate from the nearest crypt and from there on 
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run directly  to  the  external  opening.  It  is  questionable  whether  digital  rectal  examination 
might  reveal  the  internal  opening.  A tender  palpable  mass might  indicate  an  underlying 
abscess. In some cases it is possible to probe a part of the fistulous tract. Probing should be 
done with a featherlike touch and great care. Not only can it be painful, it may also create 
false tracts.
Figure 1.3 Goodsall’s rule 
Imaging
Fistulography 
Fistulography was the first imaging technique used to visualize fistulous tracts. Water-soluble 
contrast agent is injected gently to define the fistula tract, followed by anteroposterior, lateral 
and oblique x-ray images to outline the course of the fistula tract.  Fistulography has two 
major drawbacks. First, extensions of the fistulous tract may fail to fill with contrast material if 
they  are  plugged  with  debris  or  very  remote  11. Second,  the  anal  sphincter  muscles 
themselves are not directly imaged, which means that the relationship between the fistulous 
tract and the anal sphincter muscles cannot be assessed. Furthermore it is difficult to localize 
the internal opening  11. Based on these aspects fistulographic findings are both difficult to 
interpret and unreliable 12. Since the introduction of endoanal ultrasound and MR imaging this 
technique is seldom used in modern clinical practice.
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Figure 1.4 Figure 1.5
Fistulography Hydrogen enhanced ultrasound 
1= endoanal coil
2= internal anal sphincter
3= external anal sphincter
4= fistula
Endoanal ultrasound 
Endoanal ultrasound, developed by Clive Bartram, was the first technique to directly depict 
the anal sphincter complex in detail 13. Although endoanal ultrasound is simple, cheap, quick 
and well tolerated by patients 13, 14, it has also disadvantages. Insufficient penetration of the 
ultrasound beam beyond the external anal sphincter limits the ability to visualize the region 
more distant from the anal canal, with the result that extensions from the primary tract may 
be missed. Moreover, it is difficult to distinguish infection from fibrosis, because both have a 
hypoechoic appearance  15.  Imaging by endoanal ultrasound can be improved by injecting 
hydrogen peroxide into the external opening, generating the formation of small air bubbles 16. 
This changes the fistulous tract from hypoechoic to hyperechoic, and helps to distinguish the 
fistulous  tract  from  scar  tissue.  Since  MR  imaging  is  generally  available,  this  imaging 
technique is increasingly used for the preoperative classification of perianal fistulas. 
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MR Imaging 
In recent years Magnetic Resonance imaging has shown to provide accurate information 
about the relationship between the fistulous tracts and the anal sphincter muscles. The first 
reports  regarding MR imaging of  perianal  fistulas  date from the early nineties  and were 
conducted  using  a  body  coil  17-19.  Early  studies  showed  high  concordance  rates  of  MR 
imaging  with  the  findings  of  examination  under  anesthesia  17,  20.  MR imaging  was  more 
accurate than clinical assessment in detecting previously missed secondary extensions and 
in the correct assessment of the level of the fistula with respect to the sphincter muscles. MR 
imaging has been improved by the introduction  of  endocoil  receivers.  They increase the 
tissue  resolution  close  to  the  anal  canal,  providing  superior  anatomical  detail  21,  22.  The 
disadvantage of the endoanal coils is the limited ability to visualize areas more distant from 
the anal canal. It has been suggested that preoperative assessment with MR imaging will 
alter  the  surgical  treatment  in  up  to  ten  percent  of  fistulas  treated  for  the  first  time  23. 
Comparing patients with and without  preoperative MR imaging Buchanan  et al.  observed 
postoperatively a persistent fistula in 16 percent and 57 percent of the patients, respectively 
24.  MR  imaging  has  also  disadvantages.  It  is  a  rather  expensive  and  time-consuming 
technique.  Furthermore, it  is not always well  tolerated. It is not suitable for patients with 
claustrophobia. Moreover, patients with metal implants or a pacemaker cannot undergo the 
investigation. Despite these drawbacks, MR imaging is considered to be the gold standard 
for assessing and classifying perianal fistulas.
Figure 1.6 MR imaging with an endoanal 
A. Coronal
B. Sagittal
C. Axial
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Treatment
The principle goal in the treatment of perianal fistulas is fistula healing with minimal or no 
continence  disturbances.  Perianal  fistulas  passing  the  lower  third  of  the  external  anal 
sphincter can be treated with either fistulotomy (lay-open) or fistulectomy (excision).  Both 
procedures are easy to perform, provide excellent healing rates and will result in division of 
only a small portion of the external anal sphincter  25,  26. After these procedures continence 
disturbances are minimal. In case the fistula passes through the middle or upper third of the 
external anal sphincter the portion of the sphincter that needs to be divided is too large and 
continence  disturbances  are  inevitable.  Therefore,  alternative  treatment  modalities  have 
been developed, such as transanal advancement flap repair, installation of fibrin glue and the 
use of anal fistula plugs. 
Transanal advancement flap repair
Transanal advancement flap repair (TAFR) enables healing of high transsphincteric fistulas 
without dividing the anal sphincters muscles. This procedure was developed more than a 
century ago by Noble for the repair of rectovaginal fistulas. Treatment of transsphincteric 
fistulas by TAFR became a popular technique  only until the eighties. Initially,  the reported 
healing rates were high. However, in recent years, it became clear that the healing rate after 
transanal  advancement  flap repair is  lower,  varying  between 60 to 70 percent.  Although 
sphincter division is avoided during flap repair, continence disturbances have been reported 
in  up to 35 percent  of  the patients 27.  While  creating the flap,  fibers of  the internal  anal 
sphincter are used to provide strength for the flap. Theoretically, this might affect continence. 
Zimmerman and co-workers examined the influence of two different anal retractors on fecal 
continence 28.  They found that the use of a Parks’  retractor had a deteriorating effect on 
continence, while this effect was not observed after the use of a Scott retractor. Therefore, 
they advocated the use of a Scott retractor. 
Surgical technique
All patients in whom flap repair was performed at the Erasmus Medical Center underwent 
complete  mechanical  bowel  preparation  (polyethylene  glycol:  Klean-prep® Helsinn  Birex 
Pharmaceuticals,  Dublin,  Ireland).  After  induction  of  general  endotracheal  anesthesia 
metronidazole together with cefuroxime was administered intravenously. With the patient in 
prone jack-knife  position,  the  external  opening  was  enlarged  and the fistulous  tract  was 
excised as far as possible. The internal opening of the fistula was exposed using a Lone Star 
retractor (Lone Star Retractor System, Lone Star Medical Products®, Inc. Houston, TX). The 
crypt-bearing tissue around the internal opening as well as the overlying anodermis was then 
excised. The fistulous tract was cored out of the sphincters. The defect in the internal anal 
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sphincter was closed with absorbable sutures. A flap consisting of mucosa, submucosa and 
some of the most superficial fibers of the internal anal sphincter was raised from the level of 
the dentate line and mobilized over a distance of four to six cm proximally.  The flap was 
advanced and sutured to the neodentate line with absorbable sutures. Postoperatively,  all 
patients were immobilized for five days. All patients received a clear liquid diet for five days. 
During this time period metronidazole and cefuroxime were administered intravenously three 
times daily.
Figure 1.7 Transanal advancement flap repair (reprinted with the permission from P.H. Gordon)
A.  Dotted lines outline flap to be raised C. Internal opening is closed
B.  Fistula is cored out and a flap is elevated D. Flap is drawn down and sutured in place
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Author Year No.Pts Healing rate Follow-up
Oh29 1983 15 87 NS
Aguilar30 1985 151 98 range, 8 months- 7 years
Wedell31 1987 27 100 range, 18 months- 4 years
Kodner32 1993 31 87 mean, 7 months
Ozuner33 1996 19 68 median, 12 months
Miller34 1998 18 83 mean, 14 months
Schouten27 1999 44 75 median, 12 months
Ortiz35 1999 103 93 median, 12 months
Mizrahi36 2002 41 67 median, 40 months
Sonoda37 2002 48 77 median, 17 months
Van der Hagen38 2005 23 78 median, 22 months
Perez39 2006 27 93 mean, 36 months
Gustafsson40 2006 83 57      12 months
Ellis41 2007 29 69 median, 10 months
Toyanega42 2007 35 94 mean, 12 months
Ortiz43 2008 91 82 median, 42 months
Van Koperen44 2008 70 79 median, 72 months
Dubsky45 2008 34 65 median, 63 months
Alternative treatment modalities 
Fibrin Glue
Instillation of  fibrin glue for  the treatment perianal  fistulas was first  described in 1991 by 
Hjortup and Kjaergard 46. The use of fibrin glue is easy and repeatable. Complications such 
as formation  of  abscesses and new fistulous tracts are scarce  47,  48.   Early  results  were 
promising,  but  as the  procedure  gained  wide  acceptance,  more conflicting  data  became 
available including reported healing rates varying between 0 percent  49 and 74 percent  50. 
Moreover, long-term follow-up revealed that healing rates decreased markedly in time 48, 51, 52. 
Continence is not affected after treatment with fibrin glue since there is no trauma to the 
sphincter muscles. 
20
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Some authors have evaluated the additional value of fibrin glue as an adjunct to flap repair 35, 
53-55.  The  results  of  these  studies  indicate  that  instillation  of  a  surgical  adhesive  is  not 
beneficial for patients who undergo a flap repair. 
The anal fistula plug
In recent years the Surgisis® anal fistula plug (Cook Surgical Inc., Bloomington, IN) has been 
developed as an alternative to traditional fistula surgery. This plug consists of an extracellular 
matrix,  derived from the submucosa of porcine small intestine. This matrix supports host-
tissue remodeling resulting in closure of the fistulous tract and it does not encapsulate when 
implanted.  After irrigating the fistulous tract with hydrogen peroxide, the conical  device is 
placed by drawing it through the fistulous tract. It is then cut to fit and secured in the internal 
opening using a figure-of-eight suture incorporating it with the mucosa to close the internal 
opening. According to some authors this minimal invasive technique provides a simple and 
safe option in the treatment of fistulas. Initially the reported healing rates were high, up to 87 
percent 56, 57. More recently however, less promising results were reported, with healing rates 
dropping to 41 percent 58, 24 percent 59 and 14 percent 60. Ellis was the first to compare anal 
fistula  plug  closure  with  transanal  advancement  flap  repair  61.  His  retrospective  analysis 
revealed that the fistula recurred in 33 percent of the patients after flap repair and in 12 
percent of the patients after plug repair. Although this difference seems to be in favor of the 
anal fistula plug, it did not reach statistical significance. A similar finding has been reported 
by Chung  et al.62.  Recently,  two retrospective studies revealed that flap repair provides a 
significant higher healing rate than the use of an anal fistula plug  63, 64. This observation is 
supported by the outcome of a randomized trial  conducted by Ortiz  et al.  65.  They found 
fistula recurrence in 80 percent of  the patients after plug repair and in 13 percent of the 
patients after flap repair. Based on the data obtained, flap repair seems to be more favorable 
than plug repair. More randomized trials are warranted to elucidate the value of flap repair 
and plug repair in the treatment of high transsphincteric fistulas.
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Outline of the thesis
The literature  shows  that  transanal  advancement  flap  repair fails  in  one  of  every  three 
patients.  This  thesis  was  aimed at  identifying  factors  affecting  the  outcome of  transanal 
advancement flap repair. 
In  Chapter 2 the complexity of high transsphincteric fistulas was assessed with the use of 
endoanal MR imaging in order to answer the question whether more complex fistulas, such 
as  those  with  horseshoe  extensions  and  associated  abscesses,  have  a  less  favorable 
outcome.
It has been suggested that the healing rate of transanal advancement flap repair diminishes 
with time. In Chapter 3 the healing time after transanal advancement flap repair as well as 
the risk of  recurrence after  initial  fistula healing was assessed in order to determine the 
required length of follow-up.
In Chapter  4 the outcome of  repeat  flap repair,  performed in  patients  in  whom the first 
attempt had failed, is presented. The impact of these second repairs on the overall healing 
rate is described.
Impaired rectal mucosal blood flow might result in breakdown of the distal part of the flap. In 
Chapter 5 the effect of rectal mucosal blood flow on the outcome of transanal advancement 
flap repair is described.
Some authors advocate the use of a seton prior to flap repair. However, it is still not clear 
whether  this  intervention  improves  the  outcome.  Chapter  6 describes  a  study  on  the 
influence  of  preoperative  seton drainage  on the outcome of  transanal  advancement  flap 
repair.
It is generally assumed that the presence of epithelium in the fistulous tract has a detrimental 
effect  on  fistula  healing.  However,  there  is  no  evidence  for  this  assumption.  Chapter  7 
describes the impact of such epithelium lining on the healing rate of transanal advancement 
flap repair.
Little is known about the microbiological  aspects of perianal fistulas. These aspects were 
studied  with  the  use  of  both  classical  microbiological  methods  as  well  as  molecular 
microbiological methods. Chapter 8 describes the results of this study. 
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Chapter 9 discusses the data of the experimental studies of this thesis and outlines some 
future perspectives.
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The complexity of high transsphincteric fistulas
ABSTRACT
Introduction 
Transanal advancement flap repair for the treatment of high transsphincteric fistulas fails in 
one of every three patients. Until now no definite risk factors for failure have been identified. 
The question is whether the more complex fistulas, such as those with horseshoe extensions 
and associated abscesses, have a less favorable outcome. Aim of the present study was to 
answer this question.
Methods 
Between 1995 and 2007 a series of 162 patients underwent endoanal MR imaging prior to 
transanal advancement flap repair. Two investigators, without prior knowledge of the surgical 
findings, reviewed all MR images.
Results
Posterior fistulas were identified in 76 percent of the patients. These fistulas had three types 
of  extensions:  a  direct  course  (36%),  a  classic  horseshoe  extension  (23%)  or  an 
intersphincteric horseshoe extension (41%). Corresponding healing rates were 37 percent, 
81 percent and 74 percent, respectively. Anterior fistulas were observed in 23 percent of the 
patients.  These fistulas had two types of  extensions:  a direct  course (61%) or  a classic 
horseshoe extension (39%). Corresponding healing rates were 60 percent and 52 percent, 
respectively. The healing rate of fistulas with a direct course was significantly lower than the 
healing rate of fistulas with a classic or intersphincteric horseshoe extension. Lateral fistulas 
were  identified  in  one  percent  of  the  patients.  Associated  abscesses  were  found  in  47 
percent of the posterior fistulas and five percent of the anterior fistulas. Once adequately 
drained, these abscesses did not affect the outcome of transanal advancement flap repair.
Conclusion 
The complexity of  high transsphincteric  fistulas does not  affect  the outcome of  transanal 
advancement flap repair.
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 INTRODUCTION
Transanal  advancement  flap  repair  has  been  advocated  as  the  treatment  of  choice  for 
transsphincteric  fistulas  passing through the upper  and middle  third  of  the external  anal 
sphincter. This procedure enables healing of the fistula in two of every three patients without 
consequent  sphincter damage. Several  authors have tried to identify factors affecting the 
outcome  of  transanal  advancement  flap  repair  1,  2,  3,  4.  However,  until  now  no  definite 
predictive factors for failure have been identified. The question is whether the complexity of 
high transsphincteric fistulas affects the outcome of transanal advancement flap repair. Most 
of these fistulas have their internal opening at the posterior or anterior midline. From this 
point they can extend in different ways. Some fistulas have a direct course from the internal 
to  the  external  opening,  whereas  others  extend  in  a  more complex  horseshoe  manner. 
Associated abscesses are not an uncommon finding in patients with a high transsphincteric 
fistula. It is not known whether high transsphincteric fistulas with an associated abscess and 
those with a more complex course have a lower tendency to heal. 
The classic way in which horseshoe fistulas develop has been described in detail and mainly 
involves the horseshoe extension of posterior fistulas 5-10. When such a fistula penetrates the 
external anal sphincter it enters the deep postanal space, which is bounded by the levator 
ani  muscle,  the  anococcygeal  ligament,  the  coccyx  and the  anal  canal.  This  anatomical 
space communicates on both sides with the ischioanal spaces. The easiest way to extend 
from the deep postanal space is to either one or both of these ischioanal spaces, thereby 
forming  a  classic  horseshoe  extension.  However,  it  has  been  described  that  the 
circumferential  spread  may  also  occur  in  the  intersphincteric  plane,  forming  an 
intersphincteric horseshoe extension 11.  In 1900 Goodsall described in which way a fistula is 
most likely to traverse, based on the location of the external opening. His observations have 
been almost universally accepted and are commonly known as Goodsall’s rule. According to 
this rule, fistulas with an external opening posterior to a plane transverse through the centre 
of the anus are likely to have their internal opening posterior in the midline and extend in a 
curved  way  to  the  external  opening,  whereas  fistulas  with  their  external  opening  in  the 
anterior part of the anal canal are likely to originate from the nearest crypt and from there on 
run directly to the external opening. So, according to Goodsall’s rule, the majority of posterior 
fistulas  should  form a  horseshoe  extension,  while  anterior  fistulas  should  have  a  direct 
course 10. The question is whether this is true. Aim of the present study was to determine the 
exact  prevalence of  horseshoe extensions  in  posterior  and anterior  high  transsphincteric 
fistulas with the use of endoanal MR Imaging. The present study was also conducted to 
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answer  the  question  whether  the  more  complex  fistulas,  such  as  those  with  horseshoe 
extensions and associated abscesses, have a less favorable outcome. 
PATIENTS AND METHODS
Between  June  1995  and  December  2007  a  consecutive  series  of  178  patients  with  a 
cryptoglandular,  transsphincteric  fistula,  passing through the upper  or  middle third of  the 
external  anal  sphincter  underwent  transanal  advancement  flap  repair.  In  162  of  these 
patients MR imaging was performed prior to this procedure. Patients in whom no MR imaging 
was performed were excluded. Median age at time of repair was 47 (range 21 -73) years.
Exclusion criteria
Patients with a rectovaginal fistula or a fistula caused by Crohn’s disease were excluded 
from the present series.
MR Imaging
Before transanal advancement flap repair was performed all patients underwent endoanal 
MR imaging. All MR imaging examinations were performed with the use of an endoanal coil 
with  a  1.5-T  MR  imager  (Gyroscan  NT  Intera  1.5;  Philips Medical  Systems,  Best,  the 
Netherlands). The endoanal coil (Philips Medical Systems) consisted of a fixed, rectangular, 
60-mm-long rigid receiver coil with a width of 16 mm. The coil is contained within an 80-mm-
long cylindrical coil holder with a diameter of 19 mm. Before the introduction of the coil into 
the anal canal, a condom was placed over the coil and US gel was used as a lubricant. The 
coil was introduced while the patient was lying in the left lateral position. After the coil was 
introduced, each patient was carefully turned onto his back, and the position of the coil was 
rechecked. In  each  patient,  the  following  three  sequences  were  used.  Transverse T2-
weighted  contrast-enhanced  fast  field-echo  imaging  was  performed (repetition  time 
msec/echo time msec, 23/14; acquisition time, 5 minutes 39 seconds; matrix, 205 x 256; flip 
angle, 60°; field of view, 140 mm; section thickness, 2 mm with no gaps; and two signals 
acquired). Contrast-enhanced fast field-echo is a term used by Philips Medical Systems and 
does not indicate contrast material administration. Transverse T2-weighted fast spin-echo 
[SE] MR imaging was performed with and without fat saturation (5,086/100; acquisition time, 
2 minutes 23 seconds; matrix, 186 x 256; flip angle, 90°; field of view, 120 mm; section 
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thickness, 4 mm with a 0.4-mm gap; and three signals acquired). Coronal and sagittal T2-
weighted SE MR imaging was performed without fat saturation (2,454/100; acquisition time, 2 
minutes  34  seconds;  matrix,  186  x  256;  flip  angle,  90°; field  of  view,  120  mm;  section 
thickness, 4 mm with a 0.4-mm gap; and four signals acquired). 
Two investigators, without prior knowledge of the surgical findings, independently reviewed 
all  MR images. Images with disagreement were re-evaluated with both observers working 
together, and consensus was reached. 
Surgical technique
Patients  underwent  complete  mechanical  bowel  preparation  (polyethylene  glycol:  Klean-
prep® Helsinn  Birex  Pharmaceuticals,  Dublin,  Ireland).  After  induction  of  general 
endotracheal anesthesia, metronidazole (500 mg) together with cefuroxime (1500 mg) was 
administered intravenously. With the patient in prone jack-knife position, the external opening 
was enlarged and the fistulous tract was excised as far as possible. The internal opening of 
the fistula was exposed using a Lone Star retractor (Lone Star Retractor System, Lone Star 
Medical Products®, Inc. Houston, TX). The crypt-bearing tissue around the internal opening 
as well as the overlying anodermis was then excised. The fistulous tract was cored out of the 
sphincters. The defect in the internal anal sphincter was closed with absorbable sutures. A 
flap consisting of mucosa, submucosa and some of the most superficial fibers of the internal 
anal sphincter, was raised from the level of the dentate line and mobilized over a distance of 
four to six cm proximally.  The flap was advanced and sutured to the neodentate line with 
absorbable sutures. One surgeon performed all operations (WRS). 
Drainage of associated abscesses
All  associated  abscesses,  detected  with  MR  imaging,  were  drained  with  a  four-winged 
malecot  catheter.  A separate elliptical  incision  was made to gain  access to the abscess 
cavity. Through another small incision the drain was inserted, tunneled subcutaneously and 
positioned into the abscess cavity.  The abscess cavity was irrigated six  times daily  with 
saline during ten days.
Postoperative care
All patients were immobilized for five days. All patients received a clear liquid diet for five 
days. During this time period metronidazole and cefuroxime were administered intravenously 
three times daily.
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RESULTS
Of the 162 patients who underwent endoanal MR imaging prior to the flap repair the internal 
opening of the fistula was located posterior in 119 patients, anterior in 38 patients and at the 
lateral side of the anal canal in five patients. In 36 percent of the patients with an internal 
opening at the posterior midline endoanal MRI revealed a direct course of the fistula, running 
from the internal  to the external  opening in the dorsal  quadrant  (Figure 2.1).  Associated 
abscesses were found in 55 percent of these patients. The healing rate among patients with 
this fistula type was 37 percent. In 23 percent of the patients with a posterior fistula a classic 
horseshoe extension was found. In these patients the fistula passed through the external 
anal sphincter in the posterior midline, extending from that point in a horseshoe manner to 
either one or both sides (Figure 2.2). In 35 percent of these patients an associated abscess 
was detected. The healing rate was 81 percent.  In 41 percent of  the cases the posterior 
fistula extended circumferentially in the intersphincteric plane, passing through the external 
anal sphincter at either one or both lateral sides (Figure 2.3). This fistula type was associated 
with an abscess in 54 percent of the cases. The healing rate was 74 percent. The healing 
rate of posterior fistulas with a direct course was significantly lower than the healing rate of 
fistulas  with  a  classic  or  intersphincteric  horseshoe  extension  (P=0.001).  Regarding  the 
healing rate no significant difference was observed between patients with a classic and those 
with an intersphincteric horseshoe extension. 
Endoanal MRI revealed two types of anterior fistulas. The first type are the fistulas with a 
direct course between the internal opening and the external opening in the anterior quadrant. 
This fistula type was found in 61 percent  of  the patients with  an internal  opening at  the 
anterior midline. The healing rate in these patients was 52 percent. In four percent of these 
patients  an associated abscess  was  detected.  The second type  was characterized by a 
classic horseshoe extension, observed in 39 percent of the patients. The healing rate among 
these patients was 60 percent. These fistulas were associated with an abscess in six percent 
of  the cases. Anterior  fistulas showed no intersphincteric  extensions.  The healing rate of 
anterior fistulas did not significantly differ from the healing rate of posterior fistulas.
Endoanal MR imaging revealed associated abscesses in 47 percent of the patients with a 
posterior fistula and in five percent of the patients with an anterior fistula. These abscesses 
were classified as intersphincteric (18%), infralevator (13%), intralevator (51%), supralevator 
(11%) and translevator (7%). 
Intersphincteric abscesses are located in the plane between the internal and external anal 
sphincter. Infralevator abscesses are located below the levator muscle and are commonly 
known as deep postanal space abscesses. Intralevator abscesses are located in the levator 
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muscle itself. Abscesses above the pelvic floor are referred to as supralevator abscesses. 
Some abscesses are located below the levator  muscle and from there on penetrate the 
pelvic  floor  to extend above the levator  muscle.  These hourglass-shaped abscesses are 
referred to as translevator abscesses. 
Associated  abscesses  were  significantly  more  often  present  in  posterior  fistulas  than  in 
anterior fistulas. Posterior fistulas with a direct course were significantly less often associated 
with an abscess than fistulas with either a classic or intersphincteric horseshoe extension 
(table 2.1). Comparing patients with and without an associated abscess the healing rate was 
found to be 57 percent and 62 percent respectively. All abscesses were drained as described 
before.  Once  adequately  drained,  abscesses  did  not  affect  the  outcome  of  transanal 
advancement flap repair.
Internal opening Fistula type Number (%) Associated abscesses (%) Healing rate (%)
Posterior (76%)
Classic horseshoe 23 35 81
Intersphincteric horseshoe 41 54 73
Direct course 36 55 37
Total 100 47 61
Internal opening Fistula type Number (%) Associated abscesses (%) Healing rate (%)
Anterior (23%)
Classic horseshoe 39 6 60
Direct course 61 4 52
Total 100 5 55
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Table 2.2 Healing rates and prevalence of associated abscesses in high transsphincteric anterior fistulas
Table 2.1 Healing rates and prevalence of associated abscesses in high transsphincteric posterior fistulas
The complexity of high transsphincteric fistulas
Figure 2.1 Direct fistula
Figure 2.2 Classic horseshoe fistula
Figure 2.3 Intersphincteric horseshoe fistula
Figure 2.1, 2.2 and 2.3 MR images of fistulas
1= fistula, 2= internal anal sphincter, 3= external anal sphincter
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Figure 2.4 Abscesses
A = Intersphincteric abscess
B = Supralevator abscess
C = Infralevator abscess
D = Intralevator abscess
E = Translevator abscess
1= abscess, 2= internal anal sphincter, 3= external anal sphincter, 4= levator muscle, 5= fistulous tract
DISCUSSION
The  majority  of  high  transsphincteric  fistulas,  examined  in  the  present  study,  had  their 
internal opening at the posterior midline. These posterior fistulas showed three different ways 
of extension: a direct course, a classic horseshoe extension and, the most common one, an 
intersphincteric  horseshoe  extension.  Anterior  fistulas  extended  in  two  different  ways;  a 
direct course and a classic horseshoe course. The healing rate of fistulas with a direct course 
was  significantly  lower  than  the  healing  rate  of  fistulas  with  a  classic  or  intersphincteric 
horseshoe  extension.  Associated  abscesses  were  found  in  47  percent  of  the  posterior 
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fistulas and in five percent of the anterior fistulas. Once adequately drained, these abscesses 
did not affect the outcome of transanal advancement flap repair. 
The most striking finding of the present study is the poor outcome after flap repair in patients 
with a high transsphincteric fistula, traversing the external anal sphincter in a direct course to 
the external opening. This finding is difficult to explain and has not been described before. In 
our opinion it might be possible that both anterior and posterior fistulas with a direct course 
represent a more aggressive form of perianal fistulous disease. 
Another  finding  of  the  present  study  is  the  high  prevalence  of  associated  abscesses, 
especially in high transsphincteric fistulas with their internal opening at the posterior midline. 
Most of these abscesses could not be detected by physical examination. Although some of 
these abscesses presented a rather complex and bizarre course above the pelvic floor, they 
all  could  be  detected  and  drained  because  of  preoperative  MR  imaging.  Endoanal  MR 
imaging provides an useful tool for the visualization of these abscesses, enabling adequate 
drainage. The abscess cavity was deroofed, drained and irrigated during ten days with a 
malecot catheter. This might explain why these abscesses on itself had no detrimental effect 
on the outcome. Since the present study was not aimed at comparing flap repair with and 
without  drainage of associated abscesses, it  is not known what  the outcome would have 
been in case these abscesses were overlooked and not drained. 
In  most  studies  no  distinction  is  made  between  classic  and  intersphincteric  horseshoe 
extensions.  Furthermore,  the  exact  prevalence  of  these  extensions  is  not  known.  MR 
imaging  with  an  endoanal  coil,  used  in  the  present  study,  has  revealed  that  horseshoe 
extensions  of  posterior  fistulas  most  frequently  occur  in  the  intersphincteric  plane.  This 
finding  has  not  been  described  before.  Distinction  between  the  two  different  types  of 
horseshoe extensions is difficult  without  preoperative MR imaging.  During flap repair,  the 
fistulous tract is excised as far as possible, from the external opening to the exterior of the 
external anal sphincter. In case of a fistula with classic horseshoe extension a large part of 
the  fistulous  tract  can  be  excised  without  damaging  the  external  anal  sphincter.  Whilst 
treating fistulas with an intersphincteric horseshoe extension one should be aware that the 
fistulous tract penetrates the external anal sphincter closer to the external opening. In such a 
case only a limited part of the fistulous tract can be removed. Based on these considerations, 
it seems likely that preoperative imaging decreases the risk on sphincter damage in patients 
with horseshoe extensions. 
High  transsphincteric  fistulas  with  horseshoe  extensions  and  associated  abscesses  are 
considered as complex fistulas  13.  The present  study shows that the complexity of  these 
fistulas does not affect the healing rate of transanal advancement flap repair. In contrast to 
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our expectations,  the more simple fistulas with  a direct  course had a worse outcome. A 
possible explanation for this unexpected finding might be the possibility that the course of the 
fistula depends on the severity of  the fistulous disease.  The more fulminant  the fistulous 
disease,  the  more  perpendicular  the  fistula  might  traverse  the  anal  sphincter  muscles, 
resulting in a direct course to the external anal opening. Whether or not a fistula develops 
after incision and drainage of a perianal abscess might also depend on the severity of the 
fistulous  disease.  Further research is  warranted to investigate  this  aspect.  Since several 
years it is our policy to offer patients a repeat flap repair in case the first attempt has failed. In 
all  patients  who  underwent  such  a  second  procedure  complete  healing  of  the  flap  was 
observed, except at the site of the original internal opening 14. This remarkable clinical finding 
suggests  that  persistence  of  fistulas  might  be  caused  by  ongoing  disease  within  the 
remaining  fistulous  tract.  Further  research is  warranted  regarding this  aspect  in  order  to 
control this ongoing disease, thereby increasing the healing rate.
CONCLUSION
 
The complexity of high transsphincteric fistulas characterized by horseshoe extensions and 
associated abscesses does not affect the outcome of transanal  advancement flap repair. 
Horseshoe extensions occur in two of every three patients with a posterior fistula. Extension 
in the intersphincteric plane is the most frequent one. In patients with an anterior fistula, only 
classic  extensions are observed,  accounting for  20 percent  of  the cases.  Fistulas with a 
horseshoe extension have a significant better outcome than the more simple fistulas with a 
direct course.
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ABSTRACT
Introduction 
Repair  of  high  perianal  fistulas  present  a  major  challenge  to many surgeons.  Transanal 
advancement flap repair provides a useful tool  in the treatment of these fistulas. Initially, 
promising  results  have  been  reported.  More  recent  studies  indicate  that  transanal 
advancement flap repair fails in one of every three patients. Aim of the present study was to 
determine  the  appropriate  length  of  follow-up  needed  to  assess  the  healing  rate  after 
transanal advancement flap repair of high transsphincteric fistulas.
Methods 
Between 1992 and 2000 a consecutive series of 80 patients with a high transsphincteric 
fistula  of  cryptoglandular  origin  underwent  transanal  advancement  flap  repair.  Medical 
records of all patients were studied. The initial healing rate and the median healing time were 
assessed. The initial outcome was successful in 54 patients. The medical records revealed 
that only one of these patients presented with a recurrent fistula after 28 months. The other 
53 patients were sent a questionnaire in 2006. Aim of this questionnaire was to determine 
whether they had any complaints or signs of a recurrent fistula. 
Results 
The initial healing rate was 68 percent. The median healing time was 3.6 months. 
The completed questionnaire was returned by 48 patients. None of these patients reported 
any complaints or signs of a recurrent fistula. Median duration of follow-up in these patients 
was 92 months. 
Conclusion 
At a median time interval of 3.6 months fistula healing was observed in 54 patients (68%). 
Only one patient (2%) encountered a recurrence. The length of follow-up can be restricted to 
the healing time.
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 INTRODUCTION
Perianal  fistulas passing through the upper or middle third of  the external  anal  sphincter 
present  a major  challenge to many surgeons.  Despite  new treatment modalities  such as 
closure of the fistulous tract with fibrin glue or a bioprosthetic plug, transanal advancement 
flap repair  (TAFR) is  still  considered an attractive option for  the treatment  of  these high 
transsphincteric  fistulas.  Initially,  the  reported  healing  rates  varied  between  84  and  100 
percent  1-4.  More recent  studies,  however,  revealed lower  healing  rates,  varying  between 
45% and 77% 5-11. In none of these studies reported so far a distinction was made between 
persistence rate and actual recurrence rate. Therefore, it is not known to which extent these 
rates contribute to the ultimate failure rate. Furthermore, the length of follow-up required to 
assess the healing rate of TAFR has not been established yet. According to Golub and co-
workers  most  failures  were  observed within  the first  weeks after  flap  repair  12.  It  seems 
obvious that  they described persistent  fistulas rather then recurrent  fistulas,  because the 
actual recurrence rate after initial healing of the fistula was found to be only 3.28% at a mean 
follow-up of 71 months. A recent study conducted by Ortiz et al. among 91 patients revealed 
that no recurrences occurred after 12 months 13. In contrast to these findings, Van der Hagen 
et al. 8 reported that recurrences still occur many years after initial healing and the success 
rate of TAFR decreases with time. Similar findings have been described by Ozuner and co-
workers  14.  In order to determine the required length of follow-up after TAFR the present 
study was conducted aimed at evaluating the healing time after TAFR as well as the risk on 
recurrence after initial fistula healing.
METHODS
In  the  time period  between  1992  and  2000,  a  consecutive  series  of  80  patients  with  a 
transsphincteric fistula of cryptoglandular origin, passing through the middle or upper third of 
the external anal sphincter, underwent transanal advancement flap repair. The present series 
comprised 57 men and 23 women. Median age at the time of repair was 48 (range 23-73) 
years.  The first  postoperative visit  to the outpatient  clinic  occurred in six to eight  weeks. 
Thereafter all patients were seen at a two monthly interval until the fistula had healed.  Six 
months later the patients were re-examined. Healing of the fistula was defined as complete 
wound  healing  and  closure  of  all  external  openings  in  combination  with  absence  of 
symptoms. A persistent fistula was defined as a fistula without any tendency to heal after flap 
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repair. A recurrent fistula was defined as a fistula occurring after initial healing. The initial 
healing rate and the median healing time were assessed.  All patients, in whom the fistula 
healed,  were  sent  a  questionnaire  in  2006,  except  for  one  patient  who  encountered  a 
recurrent  fistula  after  28  months  after  the  procedure. Aim  of  this  questionnaire  was  to 
determine whether they had any complaints or signs of a recurrent fistula. 
Inclusion and exclusion
Only patients  with  a high  transsphincteric  fistula  of  cryptoglandular  origin  were  included. 
Patients  with  a  superficial  transsphincteric  fistula,  passing  through  the lower  third  of  the 
external anal sphincter and those with a rectovaginal fistula or a fistula caused by Crohn’s 
disease were excluded.
Surgical technique
Patients  underwent  complete  mechanical  bowel  preparation  (polyethylene  glycol).  After 
induction  of  general  endotracheal  anesthesia,  metronidazole  (500  mg)  together  with 
cefuroxime (1500 mg) was administered intravenously.  With the patient in prone jack-knife 
position,  all  external  openings  were  enlarged and all  fistulous  tract  were  cored out. The 
internal opening of the fistula was exposed using a Lone Star retractor (Lone Star Retractor 
System, Lone Star Medical Products®, Inc. Houston, TX). The crypt-bearing tissue around 
the internal opening, as well as the overlying anodermis was then excised. The fistulous tract 
was cored out of the sphincters. The defect in the internal anal sphincter was closed with 
absorbable  sutures.  A  flap  consisting  of  mucosa,  submucosa  and  some  of  the  most 
superficial fibers of the internal anal sphincter, was raised from the level of the dentate line 
and mobilized over a distance of four to six cm proximally. The base of the flap was about 
twice the width of its apex. The flap was advanced and sutured to the neodentate line with 
absorbable sutures. A single surgeon performed all operations (WRS). 
Postoperative care
All patients were immobilized for five days. During these five days a Foley catheter was given 
to obtain complete bed rest. All patients received a clear liquid diet for five days. During this 
time period metronidazole and cefuroxime were administered intravenously three times daily. 
Average duration of hospital stay was seven days.
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RESULTS
At a median time interval of 3.6 months fistula healing was achieved in 54 patients (68%). 
Study of medical records revealed only one recurrent fistula (2%).  In this subject endoanal 
MR imaging was performed to confirm the presence and course of the recurrent fistulous 
tract, which was found to be exactly the same as the original one. The other 53 patients were 
sent a questionnaire. The completed questionnaire was returned by 48 of the 53 patients. 
One patient died from unrelated cause and four patients were lost-to-follow-up caused by 
missing address data. None of the responding patients reported any complaints or signs of a 
recurrent fistula. Median duration of follow-up in these patients was 92 months (range 52-
161). 
DISCUSSION
Transanal advancement flap repair is considered an attractive treatment option for perianal 
fistulas passing through the upper or  middle third of  the external  anal sphincter.  Initially, 
healing rates between 84 and 100 percent were reported 1-4. During the last decade several 
studies have revealed considerably lower healing rates 5-11.The duration of follow-up in these 
studies is highly variable 5-10 whereas the length of follow-up required to assess the healing 
rate of flap repair is not clearly established. 
Recently, Van der Hagen et al. 8 reported that recurrences still occur many years after initial 
healing,  indicating that the outcome of TAFR decreases with time. Among a consecutive 
series of  41 patients  who  underwent  TAFR, they observed a healing  rate of  78% at  12 
months.  The  overall  healing  rate  dropped  to  56%  and  37%  after  24  and  48  months, 
respectively. Ozuner et al. have reported similar data 14. In contrast to these findings, Ortiz et 
al. found no recurrences after 12 months 13. This is in concordance with the findings reported 
by Golub and co-workers 12. In their series of 164 patients undergoing TAFR a initial healing 
rate of 94% was observed. Average healing time was six weeks. Only 60 of the 164 patients 
were available for long-term follow-up. Two of these 60 patients (3%) encountered with a 
recurrent fistula after 33 and 47 months, respectively.  These fistulas developed on a site 
remote  from the  index  fistula  and  may  thus  actually  represent  new fistulas  rather  then 
recurrent fistulas. 
In our present study the median healing time after TAFR was found to be 3.6 months. After 
initial  healing  the  recurrence  rate  was  very  low  (2%).  The  failure  rate  in  the  present 
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consecutive series was mainly due to persistence of the fistulas. These observations are in 
concordance  with  those  reported  by  Golub  and  Ortiz.  The  rather  conflicting  results  as 
reported by Van der Hagen and Ozuner are difficult to explain. The inclusion of patients with 
a  fistula  caused  by  Crohn’s  disease  might  provide  a  possible  explanation.  In  the  study 
conducted by Van der Hagen  et al. nearly one third of the patients had a perianal fistula 
caused by Crohn’s disease.  After 24 months the healing rate among these subjects was 
67%,  whereas  the healing  rate  of  52% was  observed in  patients  with  a  cryptoglandular 
fistula. Examining the recurrence rate at 48 and 72 months the authors did not differentiate 
between patients with or without Crohn’s disease. In our opinion it is therefore not justified to 
draw any conclusions concerning the recurrence rate of cryptoglandular fistulas after the first 
two years. It might be possible that the late recurrences after 48 months are mainly due to 
underlying Crohn’s disease.  It  is known that TAFR is more likely to fail  in these patients 
because of the recurrent character of the disease 7, 11. In our present series, as well as those 
studied by Ortiz and Golub patients with Crohn’s disease were excluded. The data obtained 
from these studies indicate that the recurrence rate after initial healing following TAFR is very 
low and the failure rate is mainly influenced by persistence of the fistula. In our opinion the 
length of follow-up after TAFR in patients with a high transsphincteric cryptoglandular fistula 
can therefore be restricted to the healing time.
CONCLUSION
At a median time interval of 3.6 months fistula healing was observed in 54 patients (68%). 
Only one patient (2%) encountered a recurrence. In our opinion follow-up can therefore be 
restricted to the point of time on which complete healing of the fistula is observed. 
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ABSTRACT
Introduction  
Transanal  advancement  flap  repair  has  been  advocated  as  the  treatment  of  choice  for 
transsphincteric  fistulas  passing  through  the  upper  or  middle  third  of  the  external  anal 
sphincter.  It  is not clear whether prior attempts at repair  adversely affect the outcome of 
transanal advancement flap repair. The purpose of the present study was to evaluate the 
success rate of a repeat transanal advancement flap repair and to assess the impact of such 
a second procedure on the overall healing rate of high transsphincteric fistulas and on fecal 
continence. 
Methods
Between January 2001 and January 2005 a consecutive series of 87 patients (M: F= 62: 25, 
median  age:  49  (range  27-73)  underwent  a  transanal  advancement  flap  repair.  Median 
follow-up was 15 (range 2-50) months.  Patients in whom the initial  operation failed were 
offered two further treatment options: a second flap repair or a long-term indwelling seton 
drainage. Twenty-six patients (male/female-ratio 5: 2, median age 51 (range 31-72) years) 
preferred a repeat repair. Continence status was evaluated before and after the procedures 
using the Rockwood Fecal Incontinence Severity Index.
Results
The healing rate after the first transanal advancement flap repair was 67 percent. Of the 29 
patients in whom the initial procedure failed, 26 underwent a repeat transanal advancement 
flap repair.  The healing rate after this second procedure was 69 percent,  resulting in an 
overall  success  rate  of  90  percent.  Both  before  and  after  the  first  attempt  of  transanal 
advancement flap repair the median Rockwood Fecal Incontinence Severity Index was seven 
(range 0-34).  In patients who underwent  a second transanal advancement flap repair the 
median Rockwood Fecal Incontinence Severity Index before and after this procedure was 
nine  (range  0-34)  and  eight  (range  0-34),  respectively.  None  of  these  changes  were 
statistically significant.
Conclusion
Repeat  transanal  advancement  flap  repair increases  the  overall  healing  rate  of  high 
transsphincteric fistulas from 67 percent after one attempt to 90 percent after two attempts 
without a deteriorating effect on fecal continence.
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INTRODUCTION
Transanal  advancement  flap  repair  has  been  advocated  as  the  treatment  of  choice  for 
transsphincteric perianal fistulas passing through the upper or middle third of the external 
anal sphincter. Initially, the reported healing rates varied between 84 and 100 percent 1-4.  In 
a recent study among 105 patients, conducted in two tertiary referral centers, a healing rate 
of 69 percent was found 5. Similar results were reported by other authors 6-9. It is still unclear 
whether the outcome after transanal advancement flap repair is influenced by prior attempts 
at repair. According to some authors, prior procedures, such as fistulotomy, fistulectomy and 
the use of fibrin glue adversely affect the healing rate after transanal advancement flap repair 
6, 10. However, these findings could not be confirmed by others 7, 11.  Until now data regarding 
the healing rate after repeat flap repair and the impact on fecal continence are scarce. It has 
been  suggested  that  one  single  transanal  advancement  flap  repair  may  result  in 
incontinence. The reported incidence of this side effect varies between eight and 35 percent 
2,  6,  7,  10-12.  According to some authors inclusion of  internal  anal  sphincter  fibers,  which  is 
necessary to strengthen the flap, contributes to the impairment of continence. Based on this 
assumption it is possible that a second flap repair further deteriorates fecal incontinence. Aim 
of the present study was to investigate the healing rate after a repeat flap repair and to 
assess  the  impact  of  such  a  second  procedure  on  the  overall  healing  rate  of  high 
transsphincteric fistulas. In addition fecal continence was assessed before and after the first 
and second flap repair, using the Rockwood Fecal Incontinence Severity Index 13.
PATIENTS AND METHODS
Between  January  2001  and  January  2005,  a  consecutive  series  of  87  patients  with  a 
transsphincteric fistula of cryptoglandular origin, passing through the middle or upper third of 
the external anal sphincter, underwent transanal advancement flap repair. The present series 
comprised 25 women and 62 men. Median age at the time of repair was 49 (range 27-73) 
years. Prior to the procedure all patients underwent endoanal MR imaging in order to confirm 
the transsphincteric course of the fistulous track. This imaging technique was also performed 
to identify the location of the internal opening and to detect the presence of any horseshoe 
extensions.  This  first  attempt  at  repair  failed  in  29 patients  (33%).  These subjects  were 
offered two further treatment options: a second flap repair or a long-term indwelling 
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seton drainage. Twenty-six patients (male/female-ratio 5: 2, median age 51 (range 31-72) 
years) preferred a repeat repair. Three patients were treated by the loose-seton technique. 
This loose-fitting seton is left in situ for at least three to four years. In our experience, the 
seton slowly migrates through the external  sphincter.  When it  reaches the subcutaneous 
level it is removed and the remnant of the fistulous tract is excised.
Surgical technique
Patients  underwent  complete  mechanical  bowel  preparation  (polyethylene  glycol).  After 
induction  of  general  endotracheal  anesthesia,  metronidazole  (500  mg)  together  with 
cefuroxime (1500 mg) was administered intravenously. With the patient in prone jack-knife 
position, the internal opening of the fistula was exposed using a Lone Star retractor (Lone 
Star Retractor System, Lone Star Medical Products®, Inc. Houston, TX). The crypt-bearing 
tissue around the internal opening, as well as the overlying anodermis was then excised. The 
fistulous tract was cored out of the sphincters. The defect in the internal anal sphincter was 
closed with absorbable sutures. A flap consisting of mucosa, submucosa and some of the 
most superficial fibers of the internal anal sphincter, was raised from the level of the dentate 
line and mobilized over a distance of four to six cm proximally.  The base of the flap was 
about twice the width of its apex. The flap was advanced and sutured to the neodentate line 
with absorbable sutures. A single surgeon performed all operations (WRS). Exactly the same 
surgical technique was used in both the first and the second repair.
Postoperative care
All  patients were immobilized for five days. During these five days,  a Foley catheter was 
given to obtain complete bed rest. All patients received a clear liquid diet for five days. During 
this time period metronidazole and cefuroxime were administered intravenously three times 
daily. Average duration of hospital stay was seven days.
Assessment of fecal continence
Impairment of continence was evaluated both before and after the first and second attempt, 
using the Rockwood Fecal Incontinence Severity Index (RFISI).  This is a validated index 
based on a type X frequency matrix. The matrix includes four types of leakage commonly 
found  in  the  fecal  incontinent  population:  gas,  mucus,  liquid  and  solid  stools  and  five 
frequencies: once to three times a month, once per week, twice per week, once per day, and 
twice per day. For the specification of the weighting scores patient input was used. Scores 
range from zero (total continence) to 61 (complete incontinence to solid stool on daily bases). 
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Statistical analysis  
For statistical analysis the Fisher’s exact test was used. A p-value <0.05 was considered to 
be statistically significant.
RESULTS
Median duration of follow-up was 15 months (range 2-50).  Fistula healing was observed in 
58 of the 87 patients (67 percent). Of the 29 patients in whom the initial procedure failed 26 
underwent a repeat transanal advancement flap repair. The healing rate after this second 
procedure was 69 percent, resulting in an overall success rate of 90 percent. Prior to the first 
attempt  at  transanal  advancement  flap  repair  the  median  Rockwood  Fecal  Incontinence 
Severity Index was seven (range 0-34).  The median score did not  change after  the first 
procedure. In three of these patients the RFISI improved and in three patients it worsened. In 
all other patients Rockwood Fecal Incontinence Severity Index did not change after the first 
procedure.  Before and after the second repair  the median Rockwood Fecal Incontinence 
Severity Index was nine (range 0-34) and eight (range 0-34), respectively. This change was 
not  statistically  significant.  In  one  of  these  patients  the  Rockwood  Fecal  Incontinence 
Severity  Index  improved,  in  one  it  worsened  and  in  24  patients  the  Rockwood  Fecal 
Incontinence Severity Index did not change after the second procedure. Of the eight patients 
in  whom  the  second  flap  repair  failed,  one  patient  was  successfully  treated  with 
anocutaneous advancement flap repair.  The other seven patients were treated with long-
term indwelling seton drainage.
No.Pts Median follow-up
(in months)
Healing rate Median RFISI before Median
RFISI after
First repair 87 15 67% 7 7
Second repair 26 15 69% 9 8
After two repairs 87 15 90% 8 8
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DISCUSSION
Transanal  advancement  flap  repair  has  been  advocated  as  the  treatment  of  choice  for 
transsphincteric perianal fistulas passing through the upper or middle third of the external 
anal sphincter. Initially, healing rates between 84 and 100 percent were reported 1-4. During 
the last decade several studies have revealed considerably higher recurrence rates 5-8, 10, 14. 
In a Dutch study among 105 patients, conducted in two tertiary referral centers, a recurrence 
rate of 31 percent was observed 5. Similar results have been reported by other investigators 
6-8,  10,  14.  There is some evidence that prior  attempts at  repair  are a negative predictor  of 
outcome.  A  previous  study,  conducted  at  our  own  institution  revealed  a  less  favorable 
outcome in patients who had undergone two or more previous attempts at repair, such as 
fistulotomy or fistulectomy 10. In 44 patients, who underwent a flap repair, we found that the 
healing rate was 87 percent in patients who had undergone no, or only one previous attempt 
at repair. This healing rate dropped to 50 percent in patients who had undergone two or more 
prior  attempts  at  repair.  A  similar  finding  was  observed  by  Ozuner  and  coworkers  6. 
According to others, however, the number of previous repair, does not affect the outcome of 
transanal advancement flap repair  7, 8, 11. 
Until  now data regarding the healing rate after repeat flap repair and the impact on fecal 
continence  are  scarce.  According  to  Lindsey  et  al. the  efficacy  of  a  repeat  transanal 
advancement flap repair is limited since “the scarring associated with a failed advancement 
flap compromises the changes of success with subsequent flaps” 15.  In a study conducted by 
Kodner  et  al. 4,  nine  patients  in  whom the initial  flap  repair  failed,  underwent  a  second 
operation, which was successful in all patients. In a study conducted by Mizrahi  et al. 7 12 
patients underwent repeat surgery because of initial  failure, of whom eight healed (67%). 
These two small series indicate that a repeat flap repair might be worthwhile. However, in 
none of these two studies the impact on fecal continence was assessed. The data obtained 
from our present study are in accordance with those reported by Kodner and Mizrahi. The 
healing rate of the second procedure was 69 percent. This successful outcome resulted in an 
overall healing rate of 90 percent. We do not know which factors are predictors of outcome 
and why flaps that initially failed did succeed on the second repair. We choose to report this 
data after a median follow-up of 15 months. Although this time period might seem relatively 
short, there are indicators that more than 80 percent of the recurrences occur within the first 
12  months  6.  In  a  study  conducted  by  Athanasiadis  et  al.  90  percent  recurrent  fistulas 
developed within the first year after treatment 16. 
61
Chapter 4
The reported incidence of disturbed continence following transanal advancement flap repair 
varies between eight and 35 percent 2, 4, 5, 7, 10, 11. It has been postulated that the inclusion of 
internal anal sphincter fibers, which is necessary to strengthen the flap, contributes to the 
impairment of continence 17.  A second flap also requires inclusion of internal anal sphincter 
fibers, which might result in further impairment of fecal continence.  In a previous study we 
were able to demonstrate that the use of a Parks retractor has a deteriorating effect on fecal 
continence. This side effect was not observed after flap repair with the use of a Lonestar 
retractor 18. In the present study this ring retractor, with multiple skin hooks on elastic bands, 
was also used in order to gain access to the anal canal. Although internal anal sphincter 
fibers  were  included  to  strengthen  the  second  flap  no  deterioration  of  continence  was 
observed after the repeat flap repair. Therefore it seems unlikely that inclusion of internal 
anal  sphincter  fibers  contributes  to  the  impairment  of  fecal  continence  after  transanal 
advancement flap repair. In our opinion avoidance of anal stretch during the procedure is far 
more important in reducing the risk of postoperative continence disturbances. The median 
postoperative Rockwood Fecal Incontinence Severity Index score, observed in our patients, 
was eight. It seems likely that this minor deterioration of continence did not affect the quality 
of  life of  our patients,  because it  has been reported that  only a score of  over 30 has a 
detrimental effect on quality of life 19.
Based on the data obtained from the present study it is recommended to offer all patients a 
repeat transanal advancement flap repair after a failed first flap repair.
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ABSTRACT
Introduction 
Transanal  advancement  flap  repair  provides  a  useful  tool  in  the  treatment  of  high 
transsphincteric fistulas. Recent studies indicate that transanal advancement flap repair fails 
in  one  of  every  three  patients.  Until  now,  no  definite  risk  factors  for  failure  have  been 
identified.  A previous  pilot  study,  conducted in  our  own institution,  revealed a  significant 
decrease in rectal mucosal blood flow after creation of the advancement flap. We postulated 
that impaired blood flow might result in breakdown of the distal part of the flap. This study 
was designed to evaluate the effect of rectal mucosal blood flow on the outcome of transanal 
advancement flap repair.
Methods 
Between August 2004 and June 2007 a series of 54 patients with a high transsphincteric 
fistula underwent transanal advancement flap repair. The present series comprised 34 men 
and 20 women. Median age at the time of repair was 45 (range 25-68) years. Rectal mucosal 
blood flow was determined by laser Doppler flowmetry before and after creation of the flap. 
The flow was expressed in arbitrary units.
Results
Transanal  advancement  flap  repair was  successful  in  34  patients  (63  percent).  Median 
healing  time  was  2.2  months.  Median  mucosal  blood  flow before  and  after  transanal 
advancement flap repair was 145  arbitrary units and 94  arbitrary units respectively.  This 
decrease  was  statistically  significant.  Comparing  patients  with  and  without  a  successful 
repair no differences were found regarding mucosal blood flow before and after creation of 
the flap (146 vs. 138 arbitrary units, 83 vs.104 arbitrary units).  
Conclusion 
Rectal mucosal blood flow does not affect the outcome of transanal advancement flap repair.
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 INTRODUCTION
Transanal  advancement  flap  repair  is  considered  an  attractive  treatment  option  for 
transsphincteric perianal fistulas passing through the upper or middle third of the external 
anal sphincter. It enables healing of the fistula without sphincter damage and consequent 
continence disturbances. Initially, healing rates between 84 and 100 percent were reported 1-
4. During the last decade, however, it became clear that transanal advancement flap repair 
fails in one of every three patients 5-11.  Potential risk factors for failure, such as gender, age, 
BMI, prior attempts at repair or the previous use of a seton have been analyzed. So far, no 
definite  risk  factors  have  been  identified.  A  previous  pilot-study,  conducted  in  our  own 
institution, revealed a significant decrease in rectal mucosal blood flow after creation of the 
advancement flap12. We postulated that impaired rectal mucosal perfusion might result into 
breakdown  of  the  distal  part  of  the  flap,  thereby  affecting  the  outcome  of  transanal 
advancement flap repair. This study was designed to evaluate the effect of rectal mucosal 
blood flow on the outcome of transanal advancement flap repair.
PATIENTS AND METHODS
In 61 patients who underwent transanal advancement flap repair between 2004 and 2007 
rectal mucosal blood flow (MBF) was determined by laser Doppler flowmetry before and after 
creation of the flap. In seven of these patients BioGlue® was installed as an adjunct to their 
flap repair.  Because an unexpected,  detrimental  effect  of  BioGlue® was observed,  these 
patients were excluded. Eventually, the present series comprised 54 patients, of whom 34 
were men and 20 were women. Median age at the time of repair was 45 (range 25-68) years. 
Exclusion criteria
Women with a rectovaginal fistula, patients with a perianal fistula caused by Crohn’s disease, 
and patients who underwent  concomitant instillation of BioGlue® were excluded from the 
present series.
Endoanal Magnetic Resonance Imaging
Prior to the procedure all patients underwent endoanal MR imaging in order to confirm the 
transsphincteric course of the fistulous track. This imaging technique was also performed to 
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identify the location of the internal opening and to detect the presence of any horseshoe 
extensions. 
Laser Doppler Flowmetry
Rectal mucosal blood flow was measured using the O2C® (Lea Medizin Technik, Giesen, 
Germany).  This device combines two optical  techniques,  namely laser Doppler  flowmetry 
and reflectance spectrophotometry (RS), in one optic fiber. There is no interference between 
the two techniques because they operate at different light wave ranges. In the present study 
a flat probe was used, with a measurement depth of four to six mm. Using laser Doppler 
flowmetry,  rectal mucosal blood flow is determined by analysis of the power spectra from 
moving blood cells, generated by Doppler frequencies of backscattered laser light (820 nm). 
The mucosal blood flow value is defined mathematically as the first moment of the Doppler 
power spectra, so it relates to the velocity of the erythrocytes multiplied by the number of 
moving erythrocytes, and it is described in arbitrary units (AU). Before creation of the flap, 
mucosal  blood  flow was  measured  just  above  the  dentate  line.  All  measurements  were 
performed by the same investigator. During each measurement (two minutes), the probe was 
held by hand. To prevent occlusion of the underlying microvessels, pressure to the mucosa 
was avoided. Measurement artefacts were identified by a drop in signal in the laser Doppler 
flowmetry and RS curve and a change in configuration of the RS signal. Directly after placing 
the probe on the mucosa, we observed changes in signal. However, after about one minute, 
the signal stabilized. From that moment, we started recording. During subsequent recording, 
no noteworthy changes in signal were observed. After advancing and suturing the flap to the 
neodentate  line,  the  probe  was  applied  to  the  apex  of  the  flap  and  the  recording  was 
repeated. 
Surgical Technique
Patients  underwent  complete  mechanical  bowel  preparation  (polyethylene  glycol).  After 
induction  of  general  endotracheal  anesthesia,  metronidazole  (500  mg)  together  with 
cefuroxime (1500 mg) was administered intravenously. With the patient in prone jack-knife 
position, the external opening was enlarged and the fistulous tract was excised as far as 
possible. The internal opening of the fistula was exposed using a Lone Star retractor (Lone 
Star Retractor System, Lone Star Medical Products®, Inc. Houston, TX). The crypt-bearing 
tissue around the internal opening as well as the overlying anodermis was then excised. The 
fistulous tract was cored out of the sphincters. The defect in the internal anal sphincter was 
closed with absorbable sutures. A flap consisting of mucosa, submucosa, and some of the 
most superficial fibers of the internal anal sphincter, was raised from the level of the dentate 
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line and mobilized over a distance of four to six cm proximally. The flap was advanced and 
sutured  to  the  neodentate  line  with  absorbable  sutures.  One  surgeon  performed  all 
operations (WRS). 
Postoperative Care
All patients were immobilized for five days. During these five days a Foley catheter was given 
to obtain complete bed rest. All patients received a clear liquid diet for five days. During this 
time period metronidazole and cefuroxime were administered intravenously three times daily. 
Statistical Analysis
The sample size calculation of the present study was based on results from an earlier pilot-
study. In this previous study we found a significant difference in blood flow between smoking 
and nonsmoking patients in a relatively small group of patients. The difference in blood flow 
found  in  this  previous  study  was  more  than  50  percent.  Our  assumption  was  that  this 
diminished blood flow would contribute to failure. To detect a blood flow of 40 percent less in 
the failure group, using a significance level of five percent, at least 40 patients were required 
to achieve a power of 80 percent. All measurements were analyzed using Graphpad Prism 
(version 3.0; Graphpad Software, San Diego, CA, USA). Median value of each measurement 
was determined. Changes within groups were evaluated using Wilcoxon’s signed-rank test. 
Comparison of the changes between groups was conducted using the Mann-Whitney U test. 
P ≤ 0.05 was considered to be statistically significant.
RESULTS
Transanal  advancement  flap  repair  was  successful  in  34  patients  (63  percent).  Median 
healing  time  was  2.2  months.  Median  rectal  mucosal  blood  flow  before  transanal 
advancement  flap repair  was 145 (range 29-411) AU. After  creation of  the flap the flow 
dropped  to  94  (range  4-529)  AU.  This  decrease  was  statistically  significant  (P  =  0.03; 
Wilcoxon. In patients in whom flap repair was successful, the preoperative rectal mucosal 
blood flow varied between 29 and 364 AU, with a median value of 146 AU. In the group of 
patients in whom flap repair failed, the median rectal mucosal blood flow before transanal 
advancement flap repair was 138 (range 37–411) AU. This slight difference in preoperative 
rectal mucosal blood flow between patients with a successful outcome and patients with a 
failure  was  not  statistically  significant,  neither  in  the  univariate  nor  in  the  multivariate 
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analysis.  In patients with a successful outcome, the rectal mucosal blood flow, measured 
shortly after creation of the flap, varied between four and 529 AU, with a median value of 83 
AU. In the patients who encountered a failure the median postoperative rectal mucosal blood 
flow was 104 (range 9-280) AU. This difference in postoperative rectal mucosal blood flow 
between patients with a successful outcome and patients with a failure was not statistically 
significant, neither in the univariate nor in the multivariate analysis. Among the present series 
were 22 patients who smoked cigarettes. No difference in healing rate between smoking and 
non-smoking patients was observed (64 percent vs. 63 percent, respectively). Although the 
median rectal mucosal blood flow before and shortly after transanal advancement flap repair 
was lower in smoking patients than in non-smoking patients (126 vs. 162 AU, 75 vs. 122 AU, 
respectively), these differences were not statistically significant. Patients in whom transanal 
advancement  flap  repair  was  not  successful  were  offered  two  further  treatment  options; 
repeat transanal advancement flap repair or a long-term indwelling seton. One patient did not 
want further treatment. Eleven patients underwent repeat transanal advancement flap repair, 
whereas a seton was placed in the remaining eight patients. During both procedures, careful 
examination of the primary advancement flap was performed. In all  patients the flap was 
completely healed, except at the site of the original internal opening.
Potential risk factors for failure
 OR 95% CI P-value
Flowreduction 1.00 0.99-1.01 0.82
Gender 1.83 0.49-6.90 0.37
Age 0.70 0.95-1.06 0.83
BMI 1.07 0.91-1.25 0.43
Prior attempts at repair 1.44 0.41-5.05 0.57
Smoking 0.70 0.99-1.00 0.61
Location of internal opening 3.03 0.78-11.81 0.11
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Table 5.1  Multivariate regression analysis for possible risk factor for failure
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Non-smokers Smokers
Before TAFR 62 122
After TAFR 126 75
   
DISCUSSION
Despite new treatment modalities such as closure of the fistulous tract with fibrin glue or with 
a bioprosthetic  plug,  transanal  advancement flap repair  still  provides a useful  tool  in  the 
treatment of high transsphincteric fistulas. Initially, the reported healing rates after transanal 
advancement  flap  repair  varied  between  84  and  100  percent  1-4.  In  recent  years  it  has 
become clear that flap repair fails in one of every three patients 5-11.  Until now, no definite 
factor predisposing to failure has been identified 13. 
In a previous pilot-study, designed to assess rectal mucosal blood flow before and after flap 
repair in smoking and non-smoking patients, we observed a significant decrease in rectal 
mucosal blood flow after creation of the flap 12. Furthermore, rectal mucosal blood flow was 
found  to  be  significantly  lower  in  smoking  patients,  both  before  and  after  transanal 
advancement  flap  repair.  Based  on  these  findings,  we  postulated  that  impaired  rectal 
mucosal blood flow might contribute to failure of the advancement flap. A remarkable finding 
in the present study was the wide interindividual variability in rectal mucosal blood flow. This 
wide  variability  is  difficult  to  explain.  This  calls  into  question  the  reliability  of  the 
measurements. Although laser Doppler flowmetry is a well-established technique, it has of 
course also its drawbacks. One of the major limitations is the influence of motion artifacts 14. 
Overall Success Failure
Before TAFR 145 146 138
After TAFR 94 83 104
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Table 5.3. Median MBF expressed in AU in smoking and non-smoking patients 
Table 5.2. Median MBF expressed in AU in patients with and without a successful 
outcome
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However, in the present study, artifacts could easily be identified by a drop in signal in the 
laser Doppler  flowmetry and RS curves and a change in configuration of  the RS signal. 
Directly  after  placing  the  probe  on  the  mucosa,  we  observed  great  changes  in  signal. 
However,  the  signal  stabilized  after  a  short  period.  From  that  moment  on,  we  started 
recording. During subsequent recording, no noteworthy changes in signal were observed. In 
our previous pilot study, we also observed a substantial variability in rectal mucosal blood 
flow between individuals.  Moreover,  a similar  variability  in rectal  mucosal blood flow was 
observed by other authors12, 14-17. 
In the present study we did not find any correlation between blood flow and the outcome of 
transanal  advancement  flap  repair.  This  observation  indicates  that  a  diminished  rectal 
mucosal blood flow does not have a detrimental effect on transanal advancement flap repair. 
If  impaired  rectal  mucosal  blood  flow were  a  risk  factor,  one  would  expect  a  complete 
breakdown of  the flap caused by local  necrosis  in  case of  a failure.  However,  in  all  our 
patients with a persistent fistula, we observed complete healing of the flap except at the site 
of the original internal opening. This remarkable clinical observation supports the finding of 
the  present  study  that  impaired  rectal  mucosal  blood  flow is  not  a  major  risk  factor.  In 
contrast to the finding of our previous study the difference in blood flow between smoking 
and non-smoking patients did not reach statistical significance. Several studies have been 
conducted to assess the effect  of  smoking on blood flow.  However,  the results of  these 
studies  are  rather  conflicting.  Emmanuel  and  Kamm  observed  a  detrimental  effect  of 
smoking on rectal mucosal bloodflow  13. This effect lasted for only 30 minutes. Monfrecola 
and colleagues recorded cutaneous blood flow on the tip of the third finger 18. According to 
these authors the flow decreased during and after smoking a cigarette, returning to baseline 
values  within  two  to  five  minutes.  Similar  findings  have  been  reported  by  others  16,  19. 
Although Mavroupoulos  et  al.  also  observed a  decrease in  cutaneous blood  flow of  the 
thumb,  they observed an opposite  response in  forehead skin and gingiva  20.  This  lather 
finding has been confirmed by Meekin and colleagues 20. These results, although conflicting, 
provide some evidence that smoking has a short lasting effect on blood flow.  In our present 
series none of the patients smoked for at least eight hours prior to flap repair. Therefore, it 
seems unlikely that the short-term effect of cigarette smoke did affect the blood flow in our 
study population. However, it is generally accepted that the use of tobacco is also notorious 
for  its  chronic,  detrimental  effect  on  the  microcirculation.  Comparing  smoking  and  non-
smoking subjects, Petschke et al. and Van Adrichem and coworkers observed lower baseline 
values of blood flow, recorded at the tip of the finger or thumb, in smoking subjects 16, 19. This 
difference,  however,  lacked  significance.  In  the  present  study  we  also  observed  lower 
baseline values of rectal mucosal blood flow in smoking patients. This difference also lacked 
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significance. In contrast to these findings, other authors did not observe any difference in 
baseline values in smoking patients 18, 21-23. 
Although our smoking patients had lower rectal mucosal blood flow, both before and after 
creation of the flap, this non-significant difference did not result in a lower healing rate among 
smoking patients. This finding is inconsistent with our earlier observations and those reported 
by Ellis and co-workers 24. However, two recent studies, conducted by Gustafsson et al. and 
Van Koperen and colleagues did not  reveal  any relation between smoking and impaired 
healing  25,  26.  Our earlier  observations revealed that the healing rate after flap repair  was 
significantly lower only in those patients who smoked ten or more cigarettes per day. Based 
on this observation we encouraged our patients to quit or at least reduce smoking several 
weeks  before  and after  the  operation.  Although  we  never  analyzed  the  outcome of  this 
intervention, this might have affected the healing rate among smoking patients in a positive 
way.  In the present series only five patients smoked ten or more cigarettes per day.  Our 
advice to quit  or  reduce smoking prior  to the procedure and the small  number of  heavy 
smokers in the present series might explain the difference between our previous study and 
the present one. 
CONCLUSION
 
In contrast to our expectations, the present, prospective study reveals that rectal mucosal 
blood flow does not  affect  the outcome of  transanal  advancement  flap  repair.  This  is  in 
accordance with the clinical observation that all our patients with a failure showed complete 
healing of the flap except  at  the site of the original  internal opening.  The lack of factors 
contributing to failure and the findings of the present  study suggest that failure after flap 
repair is caused by ongoing disease within the remaining fistulous tract.
ACKNOWLEDGEMENT
The authors thank J.C. Hop of the department of Biostatistics for the statistical analysis, 
D.A.M.P.J. Gommers of the department of Anesthesiology for his collaboration regarding the 
use of the O2C®, and J.J. van Wijk for his efforts in conducting the laser Doppler flowmetry 
measurements.
76
Rectal mucosal blood flow
REFERENCES
1. Wedell J, Meier zu Eissen P, Banzhaf G,et al. Sliding flap advancement for the treatment of 
high level fistulae. Br J Surg 1987;74:390-1.
2. Oh C. Management of high recurrent anal fistula. Surgery 1983;93:330-2.
3. Kodner IJ, Mazor A, Shemesh EI,et al. Endorectal advancement flap repair of rectovaginal and 
other complicated anorectal fistulas. Surgery 1993;114:682-9.
4. Aguilar PS, Plasencia G, Hardy TG, Jr., et al. Mucosal advancement in the treatment of anal 
fistula. Dis Colon Rectum 1985;28:496-8.
5. Miller GV, Finan PJ. Flap advancement and core fistulectomy for complex rectal fistula. Br J 
Surg 1998;85:108-10.
6. Schouten  WR,  Zimmerman  DD,  Briel  JW.  Transanal  advancement  flap  repair  of 
transsphincteric fistulas. Dis Colon Rectum 1999;42:1419-22.
7. Sonoda  T,  Hull  T,  Piedmonte  MR,  et  al.  Outcomes  of  primary  repair  of  anorectal  and 
rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 2002;45:1622-
8.
8. Van der Hagen SJ,  Baeten CG, Soeters PB, et  al.  Long-term outcome following mucosal 
advancement flap for high perianal fistulas and fistulotomy for low perianal fistulas: recurrent 
perianal  fistulas:  failure  of  treatment  or  recurrent  patient  disease?  Int  J  Colorectal  Dis 
2006;21:784-90.
9. Van der Hagen SJ, Baeten CG, Soeters PB, et al. Staged mucosal advancement flap for the 
treatment  of  complex  anal  fistulas:  pretreatment  with  noncutting  Setons  and  in  case  of 
recurrent multiple abscesses a diverting stoma. Colorectal Dis 2005;7:513-8.
10. Zimmerman  DD,  Delemarre  JB,  Gosselink  MP,  et  al.  Smoking  affects  the  outcome  of 
transanal mucosal advancement flap repair of transsphincteric fistulas. Br J Surg 2003;90:351-
4.
11. Mizrahi N, Wexner SD, Zmora O, et al. Endorectal advancement flap: are there predictors of 
failure? Dis Colon Rectum 2002;45:1616-21.
12. Zimmerman DD, Gosselink MP, Mitalas LE, et al. Smoking impairs rectal mucosal bloodflow--
a pilot study: possible implications for transanal advancement flap repair. Dis Colon Rectum 
2005;48:1228-32.
13. Emmanuel AV, Kamm MA. Laser Doppler measurement of rectal mucosal blood flow.  Gut. 
1999;45:64-9.
14. Rajan V, Varghese B, van Leeuwen TG, et al.  Review of methodological  developments in 
laser Doppler flowmetry. Lasers in medical science 2008; 31.
15. IJzerman RG, Serne EH, van Weissenbruch MM, et al. Cigarette smoking is associated with 
an acute impairment of microvascular function in humans. Clin Sci Lond 2003;104:247-52.
16. Petschke FT, Engelhardt TO, Ulmer H, et al. Effect of cigarette smoking on skin perfusion of 
the hand. Chirurg 2006;77:1022-6.
77
Chapter 5
17. Stec I,  Hertegard S, Juto JE. Laser Doppler measurements of the vocal fold blood micro-
circulation. J Voice 2007;21:345-54.
18. Monfrecola  G,  Riccio  G,  Savarese  C,  et  al.  The  acute  effect  of  smoking  on  cutaneous 
microcirculation blood flow in habitual smokers and nonsmokers. Dermatology 1998;197:115-
8.
19. Van  Adrichem LN,  Hovius  SE,  van  Strik  R,  et  al.  Acute  effects  of  cigarette  smoking  on 
microcirculation of the thumb. Br J Plast Surg 1992;45:9-11.
20. Mavropoulos  A,  Aars  H,  Brodin  P.  Hyperaemic  response  to  cigarette  smoking  in  healthy 
gingiva. J Clin Periodontol 2003;30:214-21.
21. Meekin TN, Wilson RF, Scott  DA, et al.  Laser Doppler flowmeter measurement of relative 
gingival and forehead skin blood flow in light and heavy smokers during and after smoking. J 
Clin Periodontol 2000;27:236-42.
22. Pellaton  C,  Kubli  S,  Feihl  F  et  al.  Blunted  vasodilatory  responses  in  the  cutaneous 
microcirculation of cigarette smokers. Am Heart J 2002;144:269-74.
23. Tur E, Yosipovitch G, Oren-Vulfs S. Chronic and acute effects of cigarette smoking on skin 
blood flow. Angiology1992;43:328-35.
24. Ellis  CN, Clark S. Effect of tobacco smoking on advancement flap repair  of complex anal 
fistulas. Dis Colon Rectum 2007;50:459-63.
25. Gustafsson UM, Graf W. Randomized clinical trial of local gentamicin-collagen treatment in 
advancement flap repair for anal fistula. Br J Surg 2006;93:1202-7.
26. Van Koperen PJ, Wind J, Bemelman WA et al. Long-term functional outcome and risk factors 
for recurrence after surgical  treatment for low and high perianal  fistulas of cryptoglandular 
origin. Dis Colon Rectum 2008;51:1475-81.
78


Chapter six
Seton drainage prior to transanal advancement flap repair: 
useful or not?
E Mitalas 
JJ van Wijk
MP Gosselink
PG Doornebosch
DDE Zimmerman
WR Schouten
Submitted for publication.
 
Seton drainage prior to transanal advancement flap repair
ABSTRACT
Introduction 
Transanal  advancement  flap  repair  provides  a  useful  tool  in  the  treatment  of  high 
transsphincteric fistulas. Recent studies indicate that transanal advancement flap repair fails 
in one of every three patients. Until now, no definite predictive factor for failure has been 
identified.  Although  some authors  have  reported that  preoperative  seton  drainage  might 
improve the outcome of transanal advancement flap repair, this could not be confirmed by 
others.  We conducted  the  present  study  to  assess  the  influence  of  preoperative  seton 
drainage on the outcome of transanal advancement flap repair in a relatively large series.
Methods 
Between December 1992 and June 2008 a consecutive series of 278 patients (M: F=179: 99, 
median age 46 (range 19–73) years) with a cryptoglandular, transsphincteric fistula, passing 
through  the  upper  or  middle  third  of  the  external  anal  sphincter  underwent  transanal 
advancement flap repair. Patients were recruited from the colorectal units of two university 
hospitals (Erasmus Medical  Center,  Rotterdam: n=211, Leiden University Medical  Center, 
Leiden: n=67). Baseline characteristics did not differ between the two clinics. Sixty-eight of 
these patients underwent preoperative seton drainage for at least two months and until the 
day of the flap repair. 
Results
Median healing time was 2.2 months. In patients without  preoperative seton drainage the 
healing  rate  was  63  percent,  whereas  the  healing  rate  was  67  percent  in  patients  who 
underwent preoperative seton drainage. This difference was not statistically significant. No 
differences in healing rates were found between the series from Leiden and Rotterdam 
Conclusion 
Preoperative seton drainage does not improve the outcome of transanal advancement flap 
repair.
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 INTRODUCTION
Perianal  fistulas passing through the upper or middle third of  the external  anal  sphincter 
present a challenge to many surgeons. Despite new treatment modalities such as closure of 
the fistulous tract with fibrin glue or a bioprosthetic plug, transanal advancement flap repair 
still provides a useful tool in the treatment of these fistulas. It enables healing of the fistula 
without  damage of  the external  sphincter  and consequent  fecal  incontinence.  Initially  the 
reported healing  rates  varied  between  84 and 100 percent  1-4.  However,  during  the  last 
decade it has become clear that transanal advancement flap repair fails in one of every three 
patients  5-11.  Until  now no definite  risk factor  for  failure  has been identified.  Recently  we 
examined the outcome of repeat flap repair in 26 patients, who encountered a failure after 
the initial procedure 12. In all these patients we noticed complete healing of the advancement 
flap, except at the site of the original internal opening. This remarkable clinical finding and 
the  lack  of  predictive  factors  for  failure  suggest  that  persistence  of  the  fistula  might  be 
caused by ongoing disease within the remaining fistulous tract. Obliteration of this tract with a 
surgical adhesive, such as fibrin glue and Bio Glue, as an adjunct to flap repair has not only 
failed to improve the healing rate, but even had a detrimental effect on the outcome  13-15. 
Some authors advocate preoperative seton drainage, since it allows drainage of the fistulous 
tract,  thereby reducing the inflammatory activity  within  the  tract  and resolving  secondary 
tracts 9, 16, 17. Although two reports 7, 9 indicate that preoperative seton drainage improves the 
healing after transanal advancement flap repair, this beneficial effect could not be confirmed 
by others 10, 14. However, the reported series were rather small and study populations were 
often  of  heterogeneous  consistency,  including  patients  with  a  rectovaginal  fistula  and 
patients with fistulas caused by Crohn’s Disease. The aim of the present study was to assess 
the effect  of  preoperative seton drainage on the outcome of  transanal  advancement flap 
repair  in  a  relatively  large  series  of  patients  with  a  high  transsphincteric  fistula  of 
cryptoglandular origin. 
PATIENTS AND METHODS
Between  December  1992  and  June  2008  a  consecutive  series  of  278  patients  with  a 
cryptoglandular,  transsphincteric  fistula  passing  through  the upper  or  middle  third  of  the 
external  anal  sphincter  underwent  transanal  advancement  flap  repair.  The patients  were 
recruited  from the  colorectal  units  of  two  university  hospitals  (Erasmus  Medical  Center, 
84
Seton drainage prior to transanal advancement flap repair
Rotterdam:  n=211,  Leiden  University  Medical  Center,  Leiden:  n=67).  Baseline  patient 
characteristics did not differ between the two clinics. Sixty-eight of these patients underwent 
preoperative seton drainage for at least two months until the day of flap repair. In the Leiden 
University Medical Center and in the Erasmus Medical Center, transanal advancement flap 
repair after preoperative seton drainage was performed in 33 and 35 patients, respectively. 
Clinical charts were studied to analyze the reason for seton placement. The present series 
comprised 179 men and 99 women. Median age at the time of repair was 46 (range, 19 – 73) 
years. 
Exclusion criteria
Patients with a rectovaginal fistula or a fistula caused by Crohn’s disease were excluded 
from the present series.
Imaging
Prior  to  flap  repair  all  patients  underwent  either  hydrogen  peroxide-enhanced  endoanal 
ultrasonography or endoanal  magnetic resonance imaging in order to assess the course of 
the transsphincteric fistulous tract. These imaging techniques were also performed to identify 
the location of the internal opening and to detect the presence of any horseshoe extensions 
and associated abscesses.
Surgical technique
Patients  referred to the Erasmus Medical  Center  underwent  complete  mechanical  bowel 
preparation (polyethylene glycol). In the Leiden University Medical Center a single phosphate 
enema was instilled on the day of the operation.  After induction of general  endotracheal 
anesthesia, metronidazole (500 mg) together with cefuroxime (1500 mg) was administered 
intravenously.  With  the  patient  in  prone  jack-knife  position,  the  seton,  if  present,  was 
removed.  The external  opening  was  enlarged  and  the  fistulous  tract  was  curetted.  The 
internal opening of the fistula was exposed using a Lone Star retractor (Lone Star Retractor 
System, Lone Star Medical Products®, Inc. Houston, TX). The crypt-bearing tissue around 
the internal opening as well as the overlying anodermis was then excised. The fistulous tract 
was cored out of the sphincters. The defect in the internal anal sphincter was closed with 
absorbable  sutures.  A  flap  consisting  of  mucosa,  submucosa  and  some  of  the  most 
superficial fibers of the internal anal sphincter, was raised from the level of the dentate line 
and mobilized over a distance of four to six centimeters proximally. The flap was advanced 
and sutured to the neodentate line with absorbable sutures. 
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Postoperative care
Patients who underwent transanal advancement flap repair at the Erasmus Medical Center in 
Rotterdam were immobilized for five days.  Patients received a clear liquid diet for five days. 
During this time period metronidazole and cefuroxime were administered intravenously three 
times daily.  The patients who underwent transanal advancement flap repair at the Leiden 
University Medical Center were immobilized for a minimum of 24 hours and did not receive 
additional antibiotics.
Follow-up
All patients visited the outpatient clinic at six and 18 weeks and 12 months postoperatively. 
Healing of the fistula was defined as complete wound healing and closure of all  external 
openings in combination with absence of symptoms.
RESULTS
The charts  of  278 consecutive  patients  who  had undergone transanal  advancement  flap 
repair for cryptoglandular, transsphincteric fistulas, passing through the upper or middle third 
of  the  external  anal  sphincter  were  analyzed.  Median  healing  time  was  2.2  months.  In 
patients without preoperative seton drainage the healing rate was 63 percent, whereas the 
healing rate was 67 percent in patients who underwent preoperative seton drainage. This 
difference was  not  statistically  significant.  No specific  reasons for  seton placement  were 
identified.  Both  university  hospitals  are  tertiary  referral  centers  and  most  patients  were 
referred from smaller district hospitals. Many surgeons in these hospitals are not confident 
with the treatment of high, transsphincteric fistulas. To our knowledge most of the referring 
surgeons performed seton drainage  until  definite  treatment.  Baseline  fistula  and patients 
characteristics  did  not  differ  between  the  patients  with  and  without  preoperative  seton 
drainage (table 6.1). No differences in healing rates were found between the series from 
Leiden and Rotterdam (table 6.2). 
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Seton No seton
Internal opening Posterior 63% 70%
Anterior 29% 26%
Lateral 7% 4%
Horseshoe extension Yes 50% 47%
No 50% 53%
Prior attempts at repair Yes 59% 56%
No 41% 44%
Gender Ratio (M : F) 2:1 2:1
Age (range) 43 (21-69) 46 (19-73)
Body Mass Index 24 25
Smoking Yes 56% 52%
No 44% 48%
Leiden Rotterdam Both centers
Seton drainage 64% 69% 67%
No seton drainage 68% 62% 63%
Overall 66% 63% 64%
.
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Table 6.1. Comparison of baseline patients and fistula characteristics between 
patients with and without preoperative seton drainage
Table 6.2. Healing rates in patients with and without preoperative seton 
drainage. 
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DISCUSSION
The main goal of the present study was to investigate whether preoperative seton drainage 
has a beneficial effect on the outcome of transanal advancement flap repair or not. In a large 
cohort  of  patients  no  difference  in  healing  rate  between  patients  with  and  without 
preoperative seton drainage was observed. 
In the past many factors that might influence the outcome, such as gender, age, body mass 
index, smoking and the number of prior attempts at repair have been analyzed. So far, no 
definite risk factor for failure has been identified. The effect of preoperative seton drainage 
has been analyzed before. However, there is still no consensus whether this intervention has 
a positive effect or not. The reported series were rather small and study populations were 
often  of  heterogeneous  consistency,  including  patients  with  a  rectovaginal  fistula  and 
patients with fistulas caused by Crohn’s disease. In a retrospective study, Sonoda and co-
workers were the first  to observe a beneficial  effect  7.  In a relatively large series of 105 
patients, 56 patients underwent preoperative seton drainage. Comparing patients with and 
without  preoperative seton drainage,  they found a healing rate of  73.2 percent  and 51.2 
percent,  respectively.  This  difference  was  statistically  significant.  However,  their  study 
included a large number of patients suffering from a rectovaginal fistula and patients with a 
fistula  caused  by  Crohn’s  disease.  Only  44  patients  presented  with  a  fistula  of 
cryptoglandular  origin.  Unfortunately,  the  authors  omitted  to  provide  data  regarding 
preoperative  seton  drainage  in  this  group  of  patients.  Van  der  Hagen  and  co-workers 
described  the  outcome  of  transanal  advancement  flap  repair  after  preoperative  seton 
drainage in 23 patients with a fistula of cryptoglandular origin  9. Five of these patients also 
had a diverting stoma. Although the healing rate was quite high (78%), no comparison was 
made with patients undergoing transanal advancement flap repair alone. Two other studies, 
conducted  by  Zimmerman  et  al.  and  by  Van  Koperen  and  co-workers  indicate  that 
preoperative  seton drainage does not  affect  the outcome of  transanal  advancement  flap 
repair 10, 14. 
The  present  series  comprised  278  patients.  Sixty-eight  of  our  patients  underwent  seton 
drainage prior to transanal advancement flap repair. Since we were not able to show any 
beneficial  effect  of  preoperative  seton  drainage  in  this  relatively  large  series,  it  seems 
unlikely  that  this  type  of  preoperative  treatment  provides  a  useful  tool  to  enhance  the 
outcome  of  transanal  advancement  flap  repair.  A  limitation  of  the  present  study  is  its 
retrospective  design  with  inherent  risk  for  selection  bias.  It  might  be  possible  that  the 
complexity of the fistula was a major reason for the referring surgeon to perform preoperative 
seton  drainage.  To analyze  this  aspect,  not  only  patient  characteristics,  but  also  fistula 
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characteristics were assessed. No differences were found in both baseline characteristics 
between  patients  with  and  those  without  preoperative  seton  drainage.  Patients  who 
underwent  seton  drainage  before  admission  to  one  of  both  university  hospitals,  did  not 
present with a more complex fistula. Clinical chart review revealed no specific reasons for 
seton placement. Many surgeons from referring district hospitals are not confident with the 
treatment of  high,  transsphincteric  fistulas. It  is  obvious that  most  of  them perform seton 
drainage to minimize complaints, to prevent acute anal sepsis and to tide over the time until 
definite treatment. Based on these aspects, the risk for selection bias seems to be minimal. 
So far, no factors have been identified that affect the outcome of transanal advancement flap 
repair. Persistence of the fistula seems to be caused by ongoing disease in the remaining 
fistulous tract. Further research is warranted to assess the impact of this ongoing disease on 
the outcome of flap repair.
CONCLUSION
 
Seton drainage prior to transanal advancement flap repair does not improve the outcome.
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Epithelialisation of high transsphincteric fistulas
ABSTRACT
Introduction 
Transanal  advancement  flap  repair  has  been  advocated  as  the  treatment  of  choice  for 
transsphincteric  fistulas  passing  through the upper  and middle  third  of  the  external  anal 
sphincter. This procedure enables healing of the fistula in two out of three patients without 
consequent continence disturbances.  It is generally assumed that chronic fistulas become 
lined with  epithelium, preventing the fistula to heal.  However,  actual  data supporting this 
hypothesis are scarce. Aim of the present study was to assess the prevalence of epithelium 
lining of the high transsphincteric fistulas and to examine the effect of this epithelialisation on 
the outcome of transanal advancement flap repair (TAFR).
Methods 
Thirty-four  patients  (M:  F=  23:  11,  median  age  46  years  (range  21-65))  with  a  high 
transsphincteric fistula of cryptoglandular origin were included. All patients underwent TAFR. 
During this  procedure the fistulous tract  was excised from the external  opening until  the 
border of the external anal sphincter. Histopathological examination of this specimen was 
performed by a pathologist without prior knowledge of the clinical data.
Results
Epithelium  lining  of  the  fistulous  tract  was  found  in  only  seven  patients  (21%).  This 
epithelialisation was complete in two patients and incomplete in five patients. Median time 
interval since onset of the fistula in patients with and those without epithelialisation was 13 
and 17 months, respectively. No difference in healing rate was found between fistulas with or 
without epithelium lining.
Conclusion 
In contrast to what is generally accepted, most perianal fistulas are not lined with epithelium. 
Epithelialisation of  high transsphincteric  fistulas does not  affect  the outcome of  transanal 
advancement flap repair.
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 INTRODUCTION
The main goal in the treatment of patients with a transsphincteric fistula, passing though the 
upper  or  middle  third  of  the  external  anal  sphincter  is  healing  of  the  fistula  without 
subsequent  damage  to  the  external  anal  sphincter.  Transanal  advancement  flap  repair 
(TAFR) provides a useful tool to obtain this goal, enabling fistula healing in two out of three 
patients.  Several  authors  have  tried  to  identify  factors  affecting  the  outcome  of  TAFR. 
However,  until  now  no  definite  factor  predisposing  to  failure  has  been  identified.  It  is 
generally assumed that chronic fistulas are lined with epithelium, preventing the fistula to 
heal. However, actual data supporting this theory are absent. So far, there is only one study 
that  analyzed how often fistulous  tracts are lined with  epithelium.  In  1995 Lunniss  et  al. 
reported the results of a study aimed at evaluating the lining of fistulous tracts. In a rather 
small series of 18 patients epithelium lining was observed in 13 of these patients 1. Although 
the authors did not report any correlation between the presence of epithelium lining and the 
outcome of  surgical  treatment,  they  suggested  that  epithelialisation  of  the  fistulous  tract 
might prevent the fistula to heal. In many papers and text books this study is cited 2-5.  Aim of 
the present study was to assess the prevalence of epithelium lining of high transsphincteric 
fistulous  tracts  and to examine its  effect  on the outcome of  transanal  advancement  flap 
repair.
PATIENTS AND METHODS
Between  June  and  December  2008  a  consecutive  series  of  34  patients  with  a 
cryptoglandular,  transsphincteric  fistula  passing  through  the upper  or  middle  third  of  the 
external anal sphincter underwent TAFR. The present series comprised 23 males and 11 
females. Median age at time of repair was 46 (range 21-64) years.
Exclusion criteria
Patients with a rectovaginal fistula or a fistula caused by Crohn’s disease were excluded 
from the present series.
Surgical technique
Patients  underwent  complete  mechanical  bowel  preparation  (polyethylene  glycol:  Klean-
prep® Helsinn  Birex  Pharmaceuticals,  Dublin,  Ireland).  After  induction  of  general 
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endotracheal anesthesia, metronidazole (500 mg) together with cefuroxime (1500 mg) was 
administered intravenously. With the patient in prone jack-knife position, the external opening 
was enlarged and the fistulous tract was excised as far as possible. The internal opening of 
the fistula was exposed using a Lone Star retractor (Lone Star Retractor System, Lone Star 
Medical Products®, Inc. Houston, TX). The crypt-bearing tissue around the internal opening 
as well as the overlying anodermis was then excised. The fistulous tract was cored out of the 
sphincters. The defect in the internal anal sphincter was closed with absorbable sutures. A 
flap consisting of mucosa, submucosa and some of the most superficial fibres of the internal 
anal sphincter, was raised from the level of the dentate line and mobilized over a distance of 
four  to six centimetres proximally. The flap was advanced and sutured to the neodentate line 
with absorbable sutures. One surgeon performed all operations (WRS). 
Postoperative care
All patients were immobilized for five days. All patients received a clear liquid diet for five 
days. During this time period metronidazole and cefuroxime were administered intravenously 
three times daily. 
Histopathological examination 
The fistulous tract was excised as far as possible from the external opening up to the outer 
border of the external anal sphincter. The outmost part of this tract, containing the original 
external  opening with  surrounding skin,  was removed.  After  fixation in  10% formalin,  the 
remaining specimen was cut in sections.  These sections were strained using the routine 
hematoxylin  and eosin stain  method. The sections were examined under the microscope 
under different magnifications.
Statistical analysis
Comparison  of  the  changes  between  groups  was  conducted  using  the  Fisher’s  exact 
probability test. The limit of statistical significance was set at P = 0.05.
RESULTS
The healing rate after TAFR was 68 percent. Median healing time was 2.3 months. Median 
follow-up was 11 (range 6-13) months. Median time interval since the onset of the fistula was 
17 months (range 5-73). Epithelium lining of the central part of the fistulous tract was found in 
seven patients (21 percent).  In two of these patients the specimen was completely lined with 
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epithelium  (figure  7.1),  while  in  five  patients  the  specimen  was  only  partly  lined  with 
epithelium (figure 7.2). In most patients (n= 27, 79 percent) the fistulous tract was lined with 
granulation tissue (figure 7.3). We found no differences in either the time interval since onset 
of the fistula or healing rate between fistulas with or without epithelium lining. 
Figure 7.1
Figure 7.2
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Figure 7.3
DISCUSSION
In the present study epithelialisation of the central part of the fistulous tract was found in 
seven  patients  (21%).  In  only  two  of  them  the  specimen  was  completely  lined  with 
epithelium, whereas in the other five patients the central part of the fistulous tract was only 
partly  lined  with  epithelium.  In  all  other  patients  (79%)  the  specimen  was  lined  with 
granulation  tissue.  Comparing  patients  with  and without  epithelialisation  of  their  fistulous 
tract, no differences were found regarding the time interval since onset of the disease and 
the healing rate of TAFR.  
In 1995 Lunniss and co-workers were the first to describe epithelium lining of perianal fistulas 
1. They observed epithelium lining in 13 out of 18 patients. They did not mention however, 
whether this epithelium lining was complete or not. Although they did not assess the impact 
of  this  epithelialisation on fistula healing,  the authors stated that  it  might  be a cause for 
persistence of  the  fistula.  Although this  report  from Lunniss  et  al. does not  provide  any 
evidence for this hypothesis, it is still generally accepted. 
Recently  Van  Koperen  and  colleagues  performed  a  study  to  assess  the  presence  of 
epithelium in the fistulous tract 7. In 18 patients with a low transsphincteric fistula they took 
biopsies from the fistulous tract from three different locations, respectively on the proximal 
side at the internal opening, in the middle of the fistulous tract and near the distal end close 
to the external opening. Epithelium was observed in the majority of patients. However, most 
epithelium was  found in  the biopsies  taken from the proximal  side,  close to the  internal 
opening. In our opinion this epithelium does not represent epithelialisation of the fistulous 
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tract since it is most likely derived from the epithelium lining of the crypts of Morgagni and the 
anal glands. Epithelium was observed in only four biopsies taken from the central part of the 
fistulous tract. This observation is similar to the findings obtained from our present study. 
Despite the fact that complete epithelialisation of the fistulous tract was present in only a 
small minority of patients, Van Koperen et al. state that epithelial lining of the fistulous tract is 
present in the majority of patients and might contribute to failure. In our opinion this study 
does not provide evidence for this hypothesis.  If epithelialisation of perianal fistulas would be 
detrimental, one should expect a worse outcome after fistulotomy compared to fistulectomy, 
since the inner lining of the fistulous tract is not completely removed during fistulotomy. 
Kiehne and co-workers assessed the role of epithelium-derived antimicrobial peptides in the 
inner lining of perianal  fistulas  6.  Based on the expression of  these peptides the authors 
concluded that epithelialisation occurs frequently in chronic fistulas as a late event and that 
the epithelium is derived from the perianal skin growing into the fistula tract. However, they 
did not describe the exact prevalence of epithelialisation. The finding of the present study 
that epithelialisation of fistulous tracts occurs in only a minority of the patients is supported by 
the report of Buchanan et al. from 2006 2 . They used a porcine model of fistula-in-ano. Eight 
pigs underwent surgical creation of three fistulas. In all these fistulas a seton was placed. 
After 26 days, the setons were removed. Two of the pigs underwent anorectal excision under 
terminal anesthesia to obtain histology. In none of these fistulas epithelium was present. The 
lumen of all fistulas was surrounded by granulation tissue, as observed in the majority of our 
patients. It is questionable whether epithelialisation of the fistulous tract would have occurred 
after a longer period of time.
In the present study epithelialisation was observed in only one out five high transsphincteric 
fistulas. Most of the fistulas were lined with granulation tissue. As already stated above, it 
has been suggested that epithelium lining develops in time. Therefore, epithelium would only 
be present in longstanding fistulas. However, in the present study the median time interval 
since onset of the fistula did not differ between patients with and without epithelium lining of 
their fistula. The presence of granulation tissue in the fistulous tracts of most of our patients 
might  represent  ongoing  inflammatory  disease,  characterized  by  pain  and  discharge  of 
purulent liquid. If complete epithelialisation of the fistulous tract would occur, it seems more 
likely that these symptoms would disappear and the patients’ only complaint would be the 
existence of an connection between the anus and the perianal skin. However, this seldom 
happens.  In  recent  years  it  has become clear  that  there are no predisposing factors  for 
failure.  Recently  we  examined  the  outcome  of  repeat  flap  repair  in  26  patients,  who 
encountered a failure after the initial procedure 8. In all these patients we noticed complete 
healing  of  the advancement  flap,  except  at  the site  of  the original  internal  opening.  This 
100
Epithelialisation of high transsphincteric fistulas
remarkable  clinical  finding  and  the  lack  of  predictive  factors  for  failure  suggest  that 
persistence of the fistula might be due to ongoing disease within the remaining fistulous tract. 
Further  studies  are  warranted  to  assess  the  pathologic,  microbiologic  or  immunologic 
characteristics of this inflammatory process.
 
  
CONCLUSION
 
In contrast to what is generally accepted, most perianal fistulas are not lined with epithelium. 
Moreover, the presence this epithelium lining does not affect the outcome of TAFR.
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ABSTRACT
Introduction 
Transanal advancement flap repair (TAFR) provides a useful tool in the treatment of high 
transsphincteric fistulas. This procedure fails in one of every three patients. There is some 
evidence that persistence of the fistula after flap repair might be the result of ongoing disease 
in the remaining fistulous tract. Infection seems to be an integral part of the pathogenesis of 
perianal  fistulas.  Conventional  microbiological  studies,  conducted  so  far,  did  not  reveal 
pathogenic bacteria as the primary cause of chronic inflammation in fistulous tracts.  The 
present pilot study was aimed to assess the presence of pathogenic bacteria in the fistulous 
tract by means of 16S ribosomal RNA (rRNA) gene sequencing. 
Methods
Between February and March 2008 a consecutive series of ten patients (M: F =8: 2, median 
age 48 (range,  28-56) years)  with  a high transsphincteric fistula of cryptoglandular  origin 
underwent  TAFR.  The  fistulous  tract  was  excised  from  the  external  opening  as  far  as 
possible.  Granulation tissue obtained from the central  part  of  this tract was examined by 
means of conventional culture technique as well as molecular microbiological techniques. 
Results
In one patient the culture was negative (10%). Aerobic or facultative organisms only were 
isolated in three patients (30%), anaerobic bacteria only in three patients (30%) and mixed 
aerobic and anaerobic flora in three patients (30%).  No mycobacterium species were grown. 
16S rDNA gene sequencing failed to identify bacteria in all but one patient, most likely as a 
result of low numbers of organisms.
Conclusion 
High  transsphincteric  fistulas  are  not  colonized  by  monocultures  of  pathogenic  bacteria. 
Based on the paucity of organisms in the fistulous tract, as demonstrated by16S rRNA gene 
sequencing,  it seems unlikely  that  infection  by  a  single  bacterial  specie  plays  a  role  in 
maintaining the fistulous disease.
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INTRODUCTION
Transsphincteric fistulas passing through the lower  third of the external  sphincter  can be 
easily treated by either classic laying open (fistulotomy) or by excision (fistulectomy). These 
procedures provide excellent healing rates and a minimal risk on postoperative incontinence 
1,  2.  However,  transsphincteric  fistulas,  passing  though  the  upper  or  middle  third  of  the 
external anal sphincter are a notorious condition. Fistulotomy or fistulectomy will  result in 
unacceptable  continence  disturbances  in  these  cases.  Therefore,  sphincter  saving 
techniques have been developed. Despite new treatment modalities such as application of 
fibrin  glue  or  the  use of  an  anal  fistula  plug,  transanal  advancement  flap  repair  (TAFR) 
remains  the  treatment  of  choice  for  patients  with  high  transsphincteric  fistulas  3.  This 
procedure  is  successful  in  two  of  every  three  patients.4 Until  now  no  definite  factor 
predisposing to failure has been identified. A previous study, conducted  in patients with a 
persistent fistula after TAFR, revealed complete healing of the flap, except at the site of the 
original internal opening  5. This observation and the lack of factors predisposing to failure 
suggest  that  persistence  of  the  fistula  is  caused  by  ongoing  disease  in  the  remaining 
fistulous  tract.  Infection  seems  to  be  an  important  part  of  the  pathogenesis  of  perianal 
fistulas. A recent study, conducted in our hospital, revealed that most perianal fistulas are 
lined with granulation tissue. The presence of granulation tissue in the fistulous tract seems 
to  indicate  an  inflammatory  process.  Some  authors  studied  the  bacteriology  of  perianal 
fistulas of cryptoglandular origin 6-9. Their reports failed to demonstrate pathogenic bacteria. 
Moreover, only small numbers of organisms were found, suggesting that permanent infection 
is not a major contributing factor to the persistence of perianal fistulas. However, these data 
were  obtained  with  the  use  of  conventional  culture  techniques.  These  cultures  require 
viability of the strains for which accurate handling of the clinical material is essential. It might 
be  that  bacteria  died  due  to  inadequate  sample  processing.  Furthermore,  conventional 
culture techniques are largely  dependent  on the type and range of  media used.  Modern 
molecular techniques that use bacterial 16S rRNA provide alternative and more sensitive 
means for the study of bacterial flora 10-12. For this technique, viability of strains is not required 
and even bacteria that have died can still  be identified.  The present study was aimed to 
assess the presence of pathogenic bacteria in the fistulous tract by means of 16S rRNA gene 
sequencing.
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PATIENTS AND METHODS
Between  February  and  March  2008  a  consecutive  series  of  ten  patients  with  a 
cryptoglandular,  transsphincteric  fistula,  passing through the upper  or  middle third of  the 
external anal sphincter underwent TAFR. The present series comprised eight males and two 
females. Median age at time of repair was 48 years (range 28-56).
Exclusion criteria
Patients with a rectovaginal fistula or a fistula caused by Crohn’s disease were excluded 
from the present series.
Excision of the specimen
With the patient  in  prone jack-knife position,  the external  opening was enlarged and the 
fistulous tract was excised as far as possible towards the outer border of the external anal 
sphincter.   The  outmost  part  of  this  tract,  containing  the  original  external  opening  with 
surrounding skin, was removed. The remaining specimen, containing the central part of the 
fistulous tract,  was immediately stored in an anaerobic container and processed within two 
hours.  After excision of the fistulous tract, metronidazole (500 mg) together with cefuroxime 
(1500 mg) was administered intravenously and a transanal  advancement flap repair  was 
performed according to the previously described technique. A single surgeon performed all 
procedures (WRS). 
Conventional microbiology
The  surgical  materials  were  immersed  in  liquid  growth  media  (including  aerobic  and 
anaerobic  blood  culture  bottles)  and  were  subjected  to  standard  aerobic  and  anaerobic 
culture using various culture media including blood , McConkey and Sauboroud agar plates.
After  incubation,  the media were examined by an experienced clinical  microbiologist  and 
pure cultures were identified. In case of such pure cultures the strains involved were stored 
for future use. In case of mixed cultures, the biomaterial was collected from the plate and 
stored in  glycerol  containing  media for  later  usage.  After  presumptive  identification,  pure 
cultures were analysed for precise species nature using Vitek technology. 
109
Chapter 8
Molecular testing
DNA extraction from the surgical material was piloted using a variety of methods. Employing 
small aliquots of an initial specimen the optimal procedure was defined on the basis of DNA 
yield. Once a protocol was established all specimens were treated similarly. DNA extracted 
from biopsies was amplified using general primers for the bacterial 16S rRNA genes. This 
involved  broad-spectrum  amplification  of  DNA  from  all  bacterial  species  known  and 
generated a mixture of PCR products.
RESULTS
Patient characteristics and the organisms cultured are shown in table 8.1. In one patient the 
culture was negative (10%).  Aerobic  or  facultative organisms only were  isolated in  three 
patients  (30%),  anaerobic  bacteria  only  in  three  patients  (30%)  and  mixed  aerobic  and 
anaerobic flora in three patients (30%). The organisms, cultured from granulation tissue in 
the  fistulous  tract  were  bowel-derived,  skin-derived  or  a  combination  of  both.  No 
mycobacterium species were grown from any of the ten patients. 
The molecular technique, used in the present study, failed to identify bacteria in all but one 
patient. In this patient  Escherichia coli was identified. Failure to detect bacteria in the other 
nine patients was most likely caused by low numbers of organisms. Therefore, the culture-
positive results were considered to be clinically insignificant.
DISCUSSION
The present  study  demonstrates  that  high  transsphincteric  fistulas  are  not  colonized  or 
infected with pathogenic bacteria. The organisms, cultured from granulation tissue, obtained 
from the fistulous tract represented bowel-derived, skin-derived or a combination of both flora 
types.  It  seems  unlikely  that  permanent  infection  with  these  bacteria  contributes  to  the 
chronicity of perianal fistulas, since they were present in such small numbers that 16S rRNA 
sequencing could not detect them. 
It  is  generally  accepted that  perianal  fistulas are secondary to  perianal  abscesses.  After 
incision and drainage of such an abscess a fistula remains in about half of the patients 13, 14. It 
is  not  clear  which  factors  contribute  to  the  development  of  a  chronic  and  persistent 
fistula.The microbiology of perianal abscesses has been well described 13, 15-17. The bacteria  
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cultured from perianal abscesses include bowel-derived organisms, skin-derived-organisms 
or  a  combination  of  both.  According  to  some  authors  bowel-derived  organisms  are 
associated with subsequent occurrence of a fistula 13, 15, 16. However, this finding could not be 
confirmed by others  18. Three studies have been conducted to assess the microbiology of 
cryptoglandular,  perianal  fistulas  6-8.  Seow-Choen  et  al.  were  the  first  to  show that  the 
microflora in perianal fistulas is similar to the microflora of perianal abscesses  8. However, 
cultures of granulation tissue, obtained from perianal fistulas, yielded much smaller numbers 
of organisms in comparison with pus obtained from perianal abscesses. Furthermore, they 
were not able to detect pathogenic bacteria. Similar findings have been reported by others 6, 
7. The conventional culture techniques, used in these studies, have several drawbacks. First, 
they  require  viable  strains.  Therefore,  accurate  handling  of  the  material  is  essential  to 
prevent  organisms  from  dying.  Second,  conventional  culture  techniques  are  largely 
dependent on the type and range of media used.  In the present study, conventional culture 
techniques  as  well  as  16S  rRNA  gene  sequencing were  used.  Molecular  diagnostic 
techniques, such as polymerase chain reaction (PCR), have been developed to aid in the 
diagnosis of bacterial infection by detecting bacterial genetic material  11,  19.  Unlike culture, 
most  molecular assays  are  designed  specifically  for  one  organism.  This  provides high 
sensitivity and specificity. However, multiple assays may be required to screen for multiple 
organisms.  Broad-range  assays,  based  on  ribosomal  genes  (rDNA), are  designed  to 
Patient Gender Age Aerobic Anaerobic mycobacteria
16S rRNA gene
sequencing
1 M 54 neg E.coli neg E. coli
2 M 43 Skinflora neg neg neg
3 M 56 Mixed flora Mixed flora neg neg
4 F 31 Pantoea spp neg neg neg
5 M 28 neg neg neg neg
6 M 55 Hemolytic streptococcus gr C Mixed flora neg neg
7 M 45 CNS gr 1 Mixed flora neg neg
8 F 52 neg Mixed flora neg neg
9 M 47 S.aureus gr 1/ skinflora neg neg neg
10 M 49 neg Peptostreptococcus
Asaccharolyticus gr 1
neg neg
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overcome this limitation. Bacterial rRNA consists of highly conserved nucleotide sequences 
that are shared by all bacterial species, interspersed with variable regions that are genus- or 
species-specific. The DNA sequences of the variable regions form the basis of phylogenetic 
classification of microbes 20. By using PCR primers that are targeted at conserved regions of 
rDNA, it is possible to design broad-range PCRs capable of detecting DNA from almost any 
bacterial species. Bacterial  identification can be revealed by nucleotide sequencing of the 
PCR product  followed  by comparison of  this sequence with  known sequences located in 
GenBank or other databases 21, 22. In the present study 16S rRNA gene sequencing failed to 
identify bacteria in all but one patient. This was most likely caused by a very low number of 
organisms. Therefore, it seems unlikely that the bacteria, cultured from granulation tissue, 
obtained from perianal fistulas contribute to the chronicity of these fistulas.  
Flap repair of high transsphincteric fistulas fails in one of every three patients  3,  4. Several 
factors that might influence the healing rate of TAFR have been analyzed. However, until 
now no definite  factor  predisposing  to failure  has been identified  and reasons for  fistula 
persistence are still not understood.  Recently we examined the outcome of repeat flap repair 
in patients, who encountered a failure after the initial procedure  5. In all patients complete 
healing of the advancement flap was observed, except  at the site of the original  internal 
opening. This remarkable clinical finding and the lack of predictive factors for failure suggest 
that persistence of the fistula might be due to ongoing disease within the remaining fistulous 
tract. The present study does not provide any evidence for the hypothesis that bacteria are 
responsible for this ongoing disease, which is in concordance with the three earlier studies, 
using conventional culture techniques. The question is whether the anal glands, which are 
considered to be the origin of cryptoglandular perianal fistulas, contribute to the chronicity 
and persistence of  perianal  fistulas.  The ducts of  the anal  glands flow into the crypts  of 
Morgagni and drain into the anal canal.  If these glands become blocked, stasis occurs and 
infection develops. Because a number of these glands branch out into the intersphincteric 
plane,  the infection can pass the internal  anal  sphincter  that  serves as a barrier  against 
bacterial  contamination.  From the  intersphincteric  plane  the  infection  may  progress  and 
extend  in  various  ways.  Recently,  ligation  of  the  intersphincteric  fistulous  tract  (LIFT-
procedure)  has  gained  attention  23-27.  During  this  procedure,  the  fistulous  tract  in  the 
intersphincteric  plane  is  identified  and  ligated  close  to  the  internal  anal  sphincter.  The 
intersphincteric  part  of  the  fistulous  tract,  including  infected  cryptoglandular  tissue,  is 
removed.  Subsequently, the defects in the internal and external anal sphincter are closed. 
The preliminary results of this procedure are promising and indicate that the intersphincteric 
part of the fistulous tract might be the origin of the chronicity and persistence of perianal 
fistulas.  Further studies are warranted to elucidate the exact role of ongoing cryptoglandular 
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disease in failure of flap repair. 
CONCLUSION
The present study demonstrates a paucity of organisms in the fistulous tract. Therefore, it 
seems unlikely that bacterial infection pays a role in maintaining the fistulous disease.
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Summary and discussion
The principle goal in the treatment of  perianal  fistulas is healing  of  the fistula,  while  the 
function of the anal sphincter remains intact. In low transsphincteric fistulas, passing through 
the lower  third of  the external  anal sphincter,  this  goal  can easily  be achieved by either 
fistulotomy (lay-open) or fistulectomy (excision). This will  result in division of only a small 
portion of the external anal sphincter and therefore continence disturbances are generally 
minimal. However, in case the fistula passes the middle or upper third of the external anal 
sphincter, the portion of the sphincter that needs to be divided is too large to maintain its 
function and continence disturbances are inevitable.  This  type of  fistula requires a more 
vigilant treatment. Despite new treatment modalities such as closure of the fistulous tract with 
fibrin  glue  or  with  a  bioprosthetic  plug,  transanal  advancement  flap  repair  remains  the 
treatment of  choice for  these fistulas.  Early reports revealed high healing rates after  the 
transanal advancement flap. In recent years, however, it became clear that the procedure 
fails in one of every three patients. This thesis was aimed at identifying factors that affect the 
outcome of the transanal advancement flap repair.
Chapter 1 provides a general introduction to this thesis. Pathogenesis, anatomy of the anal 
canal,  clinical  manifestation,  classification,  imaging techniques and treatment  options are 
briefly discussed. In addition the outline of the thesis is presented.
The course of high, transsphincteric fistulas is highly variable. Some have a direct course 
from  the  internal  to  the  external  opening,  whereas  others  extend  in  a  more  complex 
horseshoe manner. In addition, associated abscesses are not uncommon in patients with a 
high transsphincteric fistula.  Chapter 2 deals with the question whether the complexity of 
high transsphincteric fistulas affects the outcome of transanal advancement flap repair. The 
complexity of the fistulous tract and the presence of abscesses were assessed with endoanal 
MR  imaging.  Prolonged  drainage  of  all  associated  abscesses  was  performed.  The 
complexity  of  high  transsphincteric  fistulas  did  not  affect  the  outcome  of  transanal 
advancement  flap.  Associated  abscesses,  once  adequately  drained,  neither  affected  the 
outcome. The most striking finding of the present study was the fact that the most simple 
fistulas with a direct course had a significant worse outcome. A possible explanation for this 
unexpected finding might be that the course of the fistula depends on the severity of the 
fistulous disease.  The more fulminant  the fistulous disease,  the more straightforward the 
fistula might traverse the anal sphincter muscles, resulting in a direct course to the external 
anal opening.
119
Chapter 9
In  Chapter 3 the appropriate length of follow-up needed to assess the healing rate after 
transanal advancement flap repair and the risk of recurrence after initial fistula healing were 
studied. Healing of the fistula was defined as complete wound healing and closure of all 
external openings in combination with absence of symptoms. Fistula healing was observed in 
54 patients (68%). Median time interval until healing was 3.6 months. Only one patient (2%) 
encountered  a  recurrence.  Median  duration  of  follow-up  was  92  months.  In  our  opinion 
follow-up can therefore be restricted to the point of time of complete healing of the fistula. 
In  Chapter 4 the success rate of repeat transanal advancement flap repair was evaluated 
and  the  impact  of  such  a  second  procedure  on  the  overall  healing  rate  of  high 
transsphincteric fistulas and on fecal continence was assessed. Healing rate of the second 
repair was equal to the first attempt, which resulted in a substantial increase of the overall 
healing rate of high transsphincteric fistulas.  Fecal continence was not affected by such a 
second procedure. During repeat transanal advancement flap repair we observed complete 
healing  of  the flap except  at  the site of  the original  internal  opening.  This  suggests that 
persistence of fistulas might be caused by ongoing disease within the remaining fistulous 
tract. 
Chapter 5  describes a study on the effect of rectal mucosal blood flow on the outcome of 
transanal advancement flap repair. In this study laser Doppler flowmetry was used to assess 
rectal mucosal blood flow before and after creation of the advancement flap. No correlation 
was found between blood flow and the outcome of transanal advancement flap repair. This 
indicates that a diminished rectal mucosal blood flow does not have a detrimental effect on 
transanal advancement flap. If impaired rectal mucosal blood flow were a risk factor, one 
would expect a breakdown of the flap caused by local necrosis in case of a failure. However, 
in all our patients with a persistent fistula, we observed complete healing of the flap except at 
the site of the original  internal opening. This clinical  observation supports the finding that 
impaired rectal mucosal blood flow is not a major risk factor.
Seton drainage has been advocated  since it  allows drainage of the fistulous tract and is 
thereby  supposed  to  reduce  the  inflammatory  activity  within  the  tract  and  to  resolve 
secondary tracts.  This  might  have a beneficial  effect  on  the  healing  rate  after  transanal 
advancement  flap repair.  In  Chapter  6 the effect  of  preoperative seton drainage  on the 
outcome of transanal advancement flap repair was evaluated. We did not find differences in 
healing rate between patients with and without preoperative seton drainage. 
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It  is  generally believed that  chronic fistulas become lined with epithelium, preventing the 
fistula to heal. However, data supporting this theory are scarce. In Chapter 7 the presence of 
an epithelium lining of the fistulous tract was assessed and the effect of such an epithelium 
layer on the outcome of transanal advancement flap repair was examined. This revealed that 
only  a  small  part  of  the  fistulas  was  lined  with  epithelium.  Moreover,  the  presence  this 
epithelium lining did not affect the outcome of transanal advancement flap repair.
There is some evidence that persistence of the fistula after flap repair might be the result of 
ongoing disease in the remaining fistulous tract. Infection seems to be an integral part of the 
pathogenesis of perianal fistulas. Conventional microbiological studies, conducted so far, did 
not  reveal  pathogenic  bacteria  as the primary cause of  chronic  inflammation in  fistulous 
tracts. In Chapter 8 the presence of pathogenic bacteria in the fistulous tract was assessed 
by means of 16S ribosomal RNA (rRNA) gene sequencing. This pilot study revealed that 
high  transsphincteric  fistulas  are  not  colonized  by  monocultures  of  pathogenic  bacteria. 
Based on the paucity of organisms in the fistulous tract, as demonstrated by16S rRNA gene 
sequencing,  it seems unlikely  that  infection  by a single bacterial  species plays  a role in 
maintaining the fistulous disease.
Conclusions
 The  complexity  of  high  transsphincteric  fistulas  does  not  affect  the  outcome  of 
transanal advancement flap repair.
 Recurrence after  initial  healing  of  the fistula is  rare.  The length of  follow-up after 
transanal advancement flap repair can therefore be restricted to the healing time.
 Repeat  transanal  advancement  flap repair  results  in  a substantial  increase of  the 
overall  healing  rate of  high transsphincteric  fistulas without  deteriorating effect  on 
fecal continence.
 A  diminished  rectal  mucosal  blood  flow  does  not  have  a  detrimental  effect  on 
transanal advancement flap repair.
 Seton drainage prior to transanal advancement flap repair does not seem to improve 
the outcome.
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 Most perianal fistulas are not lined with epithelium. The presence of this epithelium 
lining does not affect the outcome of transanal advancement flap repair.
 High  transsphincteric  fistulas  are  not  colonized  by  monocultures  of  pathogenic 
bacteria. Based on the paucity of organisms in the fistulous tract,  it seems unlikely 
that infection by a single bacterial species plays a role in maintaining the fistulous 
disease.
Despite the fact that perianal fistulas are treated since early history,  high transsphincteric 
fistulas remain a frustrating and challenging pathology. Failure after transanal advancement 
flap repair seems more and more to be caused primarily by ongoing inflammation in the 
remaining  fistulous  tract.  Therefore,  we  performed  a  pilot-study  on  the  occurrence  of 
pathogenic  bacteria  in  the  remaining  fistulous  tracts.  This  study  suggested  that  high 
transsphincteric fistulas are not colonized by pathogenic bacteria.  This does not exclude, 
however, that non-pathogenic bacteria or their products elicit or sustain the inflammation. We 
therefore propose that future studies should be devoted to the nature of the inflammatory 
process and the underlying factors.
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Het doel bij  de behandeling van perianale fistels is het genezen van de fistel,  zonder de 
functie  van  de  externe  anale  sphincter  in  gevaar  te  brengen.  Bij  laag  transsfincterische 
fistels, die door het onderste eenderde deel van de externe anale sfincter verlopen, kan dit 
eenvoudig bereikt worden door het verrichten van een fistulotomie (klieven van de fistel) of 
fistulectomie (excideren van de fistel). Op deze manier wordt slechts een klein deel van de 
externe anale sfincter gekliefd en is de verstoring van de continentie minimaal. In het geval 
de fistel echter door het bovenste of middelste eenderde deel van de externe anale sfincter 
loopt,  zal  op  deze  wijze  een  dusdanig  groot  deel  van  de  sfincter  gekliefd  worden  dat 
verstoring  van  de  continentie  onvermijdelijk  is.  Dit  type  fistel  vraagt  dus  om  een  meer 
voorzichtige aanpak.  Ondanks nieuwe behandelmogelijkheden, zoals het opspuiten van de 
fistel  met  fibrine lijm of  het  inbrengen van een bioprosthetische plug,  blijft  de transanale 
mucosaverschuivingsplastiek de voorkeursbehandeling bij deze fistels. De eerste publicaties 
ten  aanzien  van  de  transanale  mucosaverschuivingsplastiek  rapporteerden  zeer  hoge 
slagingspercentages van deze ingreep. De afgelopen jaren is echter duidelijk geworden dat 
de  ingreep  bij  een  op  de  drie  patiënten  faalt.  Het  doel  van  dit  proefschrift  was  het 
identificeren van factoren die het resultaat van de transanale mucosaverschuivingsplastiek 
beïnvloeden. 
Hoofdstuk 1 geeft een algemene inleiding op dit proefschrift.  De pathogenese, anatomie 
van het  anale kanaal,  het  klinische beeld,  de classificatie,  beeldvormende technieken en 
behandelmogelijkheden  worden  kort  besproken.  Daarnaast  beschrijft  dit  hoofdstuk  de 
doelstellingen van dit proefschrift.
Het verloop van transsfincterische fistels kan sterk variëren. Sommige fistels hebben een 
direct verloop van de inwendige opening naar de uitwendige opening, terwijl andere op een 
meer  complexe  hoefijzervormige wijze  verlopen.  Daarnaast  zijn  geassocieerde  abcessen 
een  veel  voorkomende  bevinding  bij  patiënten  met  een  hoge  transsfincterische  fistel. 
Hoofdstuk 2 beschrijft  in hoeverre de complexiteit  van hoge transsfincterische fistels de 
uitkomst van de transanale mucosaverschuivingsplastiek beïnvloedt. De complexiteit van de 
fistel en de aanwezigheid van abcessen werden geanalyseerd met behulp van endoanale 
MRI beelden.  De complexiteit van de fistels bleek geen invloed te hebben op de uitkomst 
van  de  transanale  mucosaverschuivingsplastiek.  Ook  abcessen,  eenmaal  adequaat 
gedraineerd,  hadden  geen  negatieve  invloed  op  de  genezing.  De  meest  opmerkelijke 
bevinding was dat simpele,  directe fistels een significant  slechtere uitkomst hadden.  Een 
mogelijke verklaring hiervoor zou kunnen zijn dat het verloop van de fistel afhangt van de 
agressiviteit van de ziekte. Hoe fulminanter de ziekte is, des te agressiever de fistel de anale 
sfincter penetreert, wat resulteert in een direct verloop naar de externe anale opening.
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In Hoofdstuk 3 wordt beschreven hoe lang de duur van de follow-up moet bedragen om vast 
te  stellen  wat  het  genezingspercentage  is,  en  hoe  groot  de  kans op een  recidief  is  na 
genezing van de fistel. Genezing van de fistel werd gedefinieerd als complete wondgenezing 
en het volledig sluiten van alle openingen gecombineerd met de afwezigheid van symptomen 
passend bij een fistel. Genezing van de fistel trad op in 68 procent van de patiënten. De 
mediane duur tussen de operatie en complete genezing van de fistel was 3.6 maanden. Bij 
slechts  een patiënt  (2%) trad  een recidiverende  fistel  op.  De mediane  follow-up was 92 
maanden. Op basis van deze gegevens zijn wij  van mening dat de follow-up beperkt kan 
worden tot het moment waarop de fistel genezen is. 
In  Hoofdstuk  4 wordt  het  genezingspercentage  van  een  tweede  transanale 
mucosaverschuivingsplastiek  geëvalueerd  en  wordt  vastgesteld  wat  de  invloed  van  een 
dergelijke tweede ingreep is op het totale genezingspercentage van hoge transsfincterische 
fistels  en  op  de  continentie.  Het  genezingspercentage  van  een  tweede  transanale 
mucosaverschuivingsplastiek  was  gelijk  aan  dat  van  de  eerste.  Dit  resulteerde  in  een 
aanzienlijke toename van het totale percentage genezen patiënten. Een dergelijke tweede 
procedure had geen negatieve invloed op de fecale continentie. Tijdens de tweede ingreep 
stelden wij vast dat na de eerste ingreep de flap overal was ingegroeid, behalve op de plaats 
van de oorspronkelijke inwendige opening. Deze opmerkelijke klinische bevinding suggereert 
dat het persisteren van de fistel na de transanale mucosaverschuivingsplastiek veroorzaakt 
zou kunnen worden door het voortduren van het ziekteproces in het resterende fistelkanaal. 
Een eerdere pilot-studie,  uitgevoerd in ons ziekenhuis,  liet  een significante afname in de 
doorbloeding van het rectummucosa zien na het creëren van de flap. In Hoofdstuk 5 wordt 
de invloed van de mate van doorbloeding van het rectummucosa op de uitkomst van de 
transanale  mucosaverschuivingsplastiek  beschreven.  Met  behulp  van  laser  Doppler 
flowmetrie werd de doorbloeding van het rectummucosa gemeten voor en na het creëren 
van de flap. Wij vonden geen verband tussen de mate van doorbloeding en het slagen van 
de ingreep. Het lijkt er dus op dat een afname in de doorbloeding geen negatief effect heeft 
op de transanale mucosaverschuivingsplastiek.  Als een verminderde doorbloeding tot  het 
falen van de ingreep zou leiden, zou men loslating van de flap verwachten als gevolg van 
locale necrose. In alle patiënten bij wie de fistel persisteerde, zagen wij echter dat de flap 
volledig ingegroeid was, behalve op de plaats van de oorspronkelijke inwendige opening. 
Deze  opmerkelijke  klinische  waarneming  steunt  de  bevinding  dat  een  afgenomen 
doorbloeding niet direct een risicofactor voor falen van de uitgevoerde operatie is.
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Door  sommige  auteurs  wordt  een  setondrainage  voorafgaande  aan  de  transanale 
mucosaverschuivingsplastiek aangeraden, omdat dit drainage van het fistelkanaal mogelijk 
maakt en het op die wijze de inflammatoire activiteit in het kanaal zou kunnen verminderen, 
en secundaire fistelgangen zou laten opdrogen. Dit zou een gunstig effect hebben op de 
uitkomst van de transanale mucosaverschuivingsplastiek. In  Hoofdstuk 6 wordt het effect 
van  preoperatieve  seton  drainage  op  de  uitkomst  van  de  transanale 
mucosaverschuivingsplastiek geëvalueerd. Wij vonden geen verschil in slagingspercentage 
tussen patiënten met en zonder preoperatieve seton drainage. Seton drainage voorafgaande 
aan  de  transanale  mucosaverschuivingsplastiek  lijkt  de  uitkomst  dus  niet  te  kunnen 
verbeteren.
Algemeen wordt aangenomen dat langer bestaande fistels bekleed zijn met epitheel. Er is 
echter  weinig  bewijs  voor  deze  aanname.  In  Hoofdstuk  7 wordt  de  aanwezigheid  van 
eventuele epitheliale bekleding van het fistelkanaal onderzocht en wordt beschreven wat de 
invloed  is  van  een  dergelijke  epitheliale  bekleding  op  de  uitkomst  van  de  transanale 
mucosaverschuivingsplastiek. Slechts een klein deel van de fistels bleek bekleed te zijn met 
epitheel. De aanwezigheid van deze epitheliale bekleding bleek geen invloed te hebben op 
het slagingspercentage van de transanale mucosaverschuivingsplastiek.
Hoewel de behandeling van fistels al sinds de oudheid geschiedt, blijven hoogverlopende 
transsfincterische fistels een frustrerend chirurgisch  probleem. Het falen van de transanale 
mucosaverschuivingsplastiek lijkt  steeds meer veroorzaakt te worden door het voortduren 
van de inflammatie in het resterende fistelkanaal. Daarom hebben we in Hoofdstuk 8 een 
pilot-studie uitgevoerd om het vόόrkomen van pathogenen in dit resterende fistelkanaal te 
onderzoeken.  Uit  deze  studie  bleek  dat  hoogverlopende  transsfincterische  fistels  niet 
gekoloniseerd zijn door pathogenen. Dit sluit echter niet uit dat niet-pathogene bacteriën of 
hun  producten  de  ontsteking  in  stand houden.  Wij  stellen  daarom voor  dat  toekomstige 
studies zich richten op de aard van dit ontstekingsproces en de onderliggende factoren.
Conclusies
 De complexiteit van hoge, transsfincterische fistels heeft geen invloed op de uitkomst 
van de transanale mucosaverschuivingsplastiek.
 Recidieven na genezing van de fistel komen zelden voor. De duur van de follow-up 
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na  transanale  mucosaverschuivingsplastiek  kan  derhalve  beperkt  worden  tot  het 
tijdstip waarop de fistel volledig genezen is. 
 Een tweede transanale mucosaverschuivingsplastiek heeft  een slagingspercentage 
dat  gelijk  is  aan  een  eerste  ingreep.  Een  tweede  transanale 
mucosaverschuivingsplastiek leidt derhalve tot een aanzienlijke verbetering van het 
totale   succespercentage  van  deze  ingreep  zonder  verslechtering  van  de  fecale 
continentie.
 Een  afname van  de  doorbloeding  van  het  rectale  mucosa  heeft  geen  negatieve 
invloed op het slagingspercentage van de transanale mucosaverschuivingsplastiek.
 Seton drainage voorafgaande aan de transanale mucosaverschuivingsplastiek heeft 
geen gunstig effect op de uitkomst.
 De meeste hoge transsfincterische fistels zijn niet bekleed met epitheel. Wanneer dit 
wel het geval is, heeft de aanwezigheid van dit epitheel geen negatief effect op het 
slagingspercentage van de transanale mucosaverschuivingsplastiek.
 Hoge  transsfincterische  fistels  zijn  niet  gekoloniseerd  door  monoculturen  van 
pathogene  bacteriën.  Aangezien  er  slechts  weinig  bacteriën  aanwezig  zijn  in  het 
fistelkanaal, lijkt het onwaarschijnlijk dat een infectie, veroorzaakt door een bepaalde 
bacterie, een rol spelt in het onderhouden van de fistel.
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